Section 37

EurekaMag Full Text Articles Chapter 36,061


Bergovec, M.; Kuzman, T.; Rojnic, M.; Makovic, A. 2002: Zagreb University School of Medicine Students grades during war. Croatian Medical Journal. 43(1): 67-70, Ruary
Dooley, M.; Plosker, G.L. 2000: Zaleplon: a review of its use in the treatment of insomnia. Drugs 60(2): 413-445
Erwin, C.W. 1999: Zaleplon effectively and safely treats chronic insomnia in elderly patients. Journal of the American Geriatrics Society 47(9): S87
Langebartels, A.; Lancel, M. 2002: Zaleplon exerts variable effects after administration to rats at light or dark onset. Journal of Sleep Research 11(Suppl 1): 132
Whitaker, T. 1999: Zaleplon improves sleep safely and effectively in elderly patients with insomnia. Journal of the American Geriatrics Society 47(9): S62
Liskow, B.; Pikalov, A. 2004: Zaleplon overdose associated with sleepwalking and complex behavior. Journal of the American Academy of Child and Adolescent Psychiatry 43(8): 927-928
Zammit, G. 2000: Zaleplon vs zolpidem Differences in next-day residual sedation after middle-of-the-night administration. Journal of Sleep Research 9(Suppl 1): 214
Cubero Pardo, P.; Rodriguez, F.Javier 2000: Zalophus californianus en Costa Rica. Revista de Biologia Tropical 48(1): 273
Cubero Pardo, P.; Rodriguez, F.Javier 2000: Zalophus californianus in Costa Rica. Revista de Biologia Tropical 48(1): 273
Mayeya, J.; Chazulwa, R.; Mayeya, P.Ntambo.; Mbewe, E.; Magolo, L.Mwape.; Kasisi, F.; Bowa, A.Chishimba. 2004: Zambia mental health country profile. International Review of Psychiatry 16(1-2): 63-72
Groves, L.; Shellenberger, M.K.; Wallace, J.D.; Hill, J.M. 1999: Zanaflex dosing Patient assessment of benefit at escalating doses. Neurology 52(6 Suppl 2): A134
Aoki, F.Y.; Hayden, F.G. 1999: Zanamivir. a potent and selective inhibitor of influenza a and B viruses. Clinical Pharmacokinetics 36(Suppl 1): V
Freund, B.; Gravenstein, S.; Elliott, M.; Miller, I. 1999: Zanamivir: a review of clinical safety. Drug Safety 21(4): 267-281
Dunn, C.J.; Goa, K.L. 1999: Zanamivir: a review of its use in influenza. Drugs 58(4): 761-784
Cheer, S.M.; Wagstaff, A.J. 2002: Zanamivir: an update of its use in influenza. Drugs 62(1): 71-106
Murrell, M.T.; Porotto, M.; Greengard, O.; Moscona, A. 2003: Zanamivir resistant parainfluenza virus type 3 Mechanisms of resistance and alterations in membrane fusion. Pediatric Research 53(4 Part 2): 320A
Orchard, J.A.; Ibbotson, R.E.; Davis, Z.A.; Gardiner, A.C.; Hamblin, T.J.; Oscier, D.G. 2002: Zap-70 Evaluation by Flow Cytometry Is a Significant Prognostic Marker in B-CLL. Blood 100(11): Abstract No. 630
Del Giudice, I.; Matutes, E.; Morilla, A.; Morilla, R.; Burford, A.; Maravelaki, S.; Osuji, N.; Owusu Ankomah, K.; Brito Babapulle, V.; Catovsky, D. 2004: Zap-70 expression in CLL Correlation with clinical and biological features. British Journal of Haematology 125(Suppl 1): 11
Zantek, N.D.; Cheson, B.D.; Hartmann, D.P.; Mavromatis, B.; Abbasi, S.; Ozdemirli, M. 2003: Zap-70 expression in lymphoid tissue and B-cell lymphomas using immunohistochemistry. Blood 102(11): 283b
Rassenti, L.Z.; Huynh, L.; Toy, T.L.; Gribben, J.G.; Keating, M.J.; Rai, K.R.; Flinn, I.W.; Byrd, J.C.; Kay, N.E.; Greaves, A.; Weiss, A.; Kipps, T.J. 2003: Zap-70 is a more reliable marker of disease progression risk than immunoglobulin mutation status in chronic lymphocytic leukemia. Blood 102(11): 34a
Del Poeta, G.; Gattei, V.; Del Principe, M.I.; Degan, M.; Maurillo, L.; Bomben, R.; Venditti, A.; Buccisano, F.; Consalvo, M.I.; Dal Bo, M.; Marini, R.; Cox, M.C.; Meoni, G. 2003: Zap-70 protein tyrosine kinase is a powerful prognostic indicator in B-cell chronic lymphocytic leukemia. Blood 102(11): 666a
Bird, A.; Mccall, K.; Herbig, A.; Mooney, M.; Eide, D.; Winge, D. 2004: Zap1, a zinc sensing transcription factor in yeast. FASEB Journal 18(4-5): Abstract 273
Wiestner, A.; Rosenwald, A.; Barry, T.; Ibbotson, R.E.; Stetler Stevenson, M.; Orchard, J.A.; Wilson, W.H.; Hamblin, T.J.; Oscier, D.G.; Staudt, L.M. 2002: Zap70 Expression Identifies B-CLL with Unmutated Immunoglobulin Genes, Worse Clinical Outcome and a Distinct Gene Expression Profile. Blood 100(11): Abstract No. 631
Murillo, G.; Hirschelman, W.H.; Kosmeder, J.W.; Moriarty, R.M.; Pezzuto, J.M.; Mehta, R.G. 2002: Zapotin, a novel chemopreventive agent inhibits azoxymethane-induced aberrant crypt formation in CF-1 mice. Proceedings of the American Association for Cancer Research 43: 125
Lancet, J.E.; Karp, J.E.; Gotlib, J.; Liesveld, J.L.; Kaufmann, S.H.; Gojo, I.; Greenberg, P.L.; Meschinchi, S.; Adjei, A.; Tidwell, M.; Messina, P.; Greer, J. 2002: ZarnestraTM in Previously Untreated Poor-Risk AML and MDS Preliminary Results of a Phase II Trial. Blood 100(11): Abstract No. 2200
Harousseau, J.L.; Reiffers, J.; Lowenberg, B.; Thomas, X.; Huguet, F.; Fenaux, P.; Stone, R.M.; Lancet, J.; Arani, R.; Rackoff, W.; Thibault, A. 2003: ZarnestraTM in patients with relapsed and refractory acute myelogenous leukemia Results of a multicenter phase 2 Study. Blood 102(11): 176a
Leppa, M.; Hamalainen, H. 2001: Zavreliella marmorata A chironomid species new to Finland from Lake Pohjalampi, North Karelia. Entomologica Fennica 12(1): 44-45, 15 June
Presnell, S.R.; Gao, Z. 2004: Zcys6 a member of the cystatin superfamily. Official Gazette of the United States Patent and Trademark Office Patents 1280(2)
Tvrtkovic, N.; Kucinic, M. 1999: Zdravko Lorkovic Short biography and scientific work. Nota Lepidopterologica 22(4): 296-305
Gil, A.F. 2003: Zea mays on the south American periphery Chronology and dietary importance. Current Anthropology 44(2): 295-300
Hagler, W.M.J.; Towers, N.R.; Mirocha, C.J.; Eppley, R.M.; Bryden, W.L. 2001: Zearalenone Mycotoxin or mycoestrogen?. Summerell, Brett A , Reprint Author, Leslie, John F, Backhouse, David, Bryden, Wayne L, Burgess, Lester W Fusarium: Paul E Nelson memorial symposium: 321-331
Yokthongwattana, K.; Polle, J.E.W.; Melis, A. 2000: Zeaxanthin accumulation upon irradiance stress of the unicellular green alga Dunaliella salina. Plant Biology (Rockville) : 166
Talbott, L.D.; Zhu, J.; Han, S.W.; Zeiger, E. 2001: Zeaxanthin and phytochrome-mediated stomatal opening in orchid. Plant Biology (Rockville) : 101
Wielgus, S.J.; Fettes, A.L.; Reed Andersen, T. 2001: Zebra mussel Benthic macroinvertebrate dynamics of the lower Green Bay, Lake Michigan. Ecological Society of America Annual Meeting Abstracts 86: 360
Kim, G.W.; Kwon, T.; Gearhiser, M.R.; Marschall, E.A.; Fisher, S.W.; Stein, R.A. 2003: Zebra mussel and round goby invasions in Lake Erie PCB biomagnification to smallmouth bass and interactions with benthic macroinvertebrates. IAGLR Conference Program and Abstracts 46: 131
Brazner, J.C.; Jensen, D.A. 2000: Zebra mussel colonization of rusty crayfish. American Midland Naturalist 143(1): 250-256
Fettes, A.L.; Reed Andersen, T.; Wielgus, S.J. 2001: Zebra mussel distribution in the lower Green Bay, Lake Michigan. IAGLR Conference Program and Abstracts 44: 38
Raikow, D.F.; Sarnelle, O.; Wilson, A.; Hamilton, S.K. 2002: Zebra mussel impacts on phytoplankton across a productivity gradient in Michigan lakes. Ecological Society of America Annual Meeting Abstracts 87: 242
Stewart, K.M. 2003: Zebra mussel population dynamics in time and space. IAGLR Conference Program and Abstracts 46: 142-143
Mihuc, T.B.; Battle, J.M.; Mihuc, J.R.; Bryan, C.F.ed 1999: Zebra mussel seasonal colonization patterns in a sub-tropical floodplain river. Hydrobiologia 392(2): 121-128
Vanderploeg, H.A.; Liebig, J.R.; Carmichael, W.W.; Agy, M.A.; Johengen, T.H.; Fahnenstiel, G.L.; Nalepa, T.F. 2001: Zebra mussel selective filtration promoted toxic Microcystis blooms in Saginaw Bay and Lake Erie. Canadian Journal of Fisheries and Aquatic Sciences 58(6): 1208-1221
Mayer, C.M.; Rudstam, L.G.; Mills, E.L.; Cardiff, S.G.; Bloom, C.A. 2001: Zebra mussels , habitat alteration, and yellow perch foraging System-wide effects and behavioural mechanisms. Canadian Journal of Fisheries and Aquatic Sciences 58(12): 2459-2467
Mayer, C.M.; Zhu, B.; Fitzgerald, D.; Mills, E.L.; Rudstam, L.G. 2003: Zebra mussels Benthic ecosystem engineers. American Fisheries Society Annual Meeting 133: 274
Pagano, J.J.; Johns, C. 2002: Zebra mussels as environmental biomonitors Short-term temporal variation in PCB congener pattern and concentration. Abstracts of Papers American Chemical Society 224(1-2): ENVR 108
Shukla, V.; King, K.N.; Ram, J.L. 2003: Zebra mussels at the freshwater/sea interface Ionic and osmotic challenges to oocyte structural integrity. SICB Annual Meeting and Exhibition Final Program and Abstracts : 304
Bartsch, L.A.; Richardson, W.B.; Sandheinrich, M.B. 2003: Zebra mussels limit food for larval fish in turbulent systems A bioenergetics analysis. Hydrobiologia 495: 59-72, 15 March
Watzin, M.C.; Lescaze, M.; Cobb, S.; Cohn, A.B. 2000: Zebra mussels, shipwrecks, and the ecological health of Lake Champlain. IAGLR Conference Program and Abstracts 43: A - 167
Plagge, A.; Sendtner Voelderndorff, L.; Sirim, P.; Rader, C.; Sonderegger, P.; Brummendorf, T. 2000: Zebra stripes in the cerebellum Identification of a neurite outgrowth-related protein expressed in sagittal zones in the cerebellar cortex. European Journal of Neuroscience 12(Suppl 11): 276
Gregory, M.J.; Jagadeeswaran, P. 2001: Zebrafish A genetic model for vascular occlusion. FASEB Journal 15(5): A1102
Dooley, K.; Zon, L.I. 2000: Zebrafish: a model system for the study of human disease. Current Opinion in Genetics and Development 10(3): 252-256
Langheinrich, U. 2003: Zebrafish: a new model on the pharmaceutical catwalk. Bioessays: News and Reviews in Molecular Cellular and Developmental Biology 25(9): 904-912
Schulte Merker, Stefan 2000: Zebrafish A vertebrate model for target discovery and functional validation. Naunyn-Schmiedeberg's Archives of Pharmacology 362(4-5 Suppl): R14
Dlugos, C.A.; Rabin, R.A. 2003: Zebrafish Animal models for FAS?. Alcoholism Clinical and Experimental Research 27(5 Suppl): 86A
Sleptsova Friedrich, I.; Emelyanov, A.; Korzh, V. 2001: Zebrafish FGFR3 and development of the MHB. Development Growth and Differentiation 43(Suppl): S80
Emelyanov, A.V.; Sleptsova Friedrich, I.L.; Korzh, V.P. 2000: Zebrafish Frizzled 7-2 acts in determination of polarity of enveloping layer. Cell Biology International 24(12): 948
Emelyanov, A.; Sleptsova Friedrich, I.; Korzh, V. 2001: Zebrafish Frizzled 7b and polarity of enveloping layer. Development Growth and Differentiation 43(Suppl): S57
Mcclintock, J.M.; Prince, V.E. 1999: Zebrafish Hox genes and vertebrate evolution. Developmental Biology 210(1): 188
Ayaso, E.; Nolan, K.; Byrnes, L. 1999: Zebrafish IGF-I receptor expression during development. Growth Hormone and IGF Research 9(5): 347
Oda, T.; Kim, C.H.; Chandrasekharappa, S.C.; Chitnis, A.B. 1999: Zebrafish Jagged homologues are associated with tissue boundaries and ectodermal placodes. Society for Neuroscience Abstracts 25(1-2): 1543
Henry, C.A.; Crawford, B.D.; Hille, M.B. 2001: Zebrafish Paxillin and Fak are necessary for normal development. Developmental Biology 235(1): 188
Mueller, J.; Melgar, T.; Schier, A.; Westerfield, M.; Varga, Z.M. 2001: Zebrafish Smoothened functions in ventral forebrain, lens, and pituitary cell specification. Biology of the Cell 93(3-4): 245
Rodino Klapac, L.; Beattie, C.E. 2003: Zebrafish Topped is functioning in a subset of fast muscle cells to allow stereotyped axon outgrowth. Developmental Biology 259(2): 592
Smolinsky,A.N.; Doughman,J.M.; Kratzke,L.T.C.; Lassiter,C.S. 2010: Zebrafish androgen receptor sequence homology and up-regulation by the fungicide vinclozolin. Comparative Biochemistry And Physiologyxicology and Pharmacology: 2, 161-174
Miyake, A.; Kitamura, K. 2001: Zebrafish arx expressed in caudal prosencephalon induces the midbrain-hindbrain boundary. Development Growth and Differentiation 43(Suppl): S83
Amatruda, J.F.; Shepard, J.L.; Stern, H.M.; Zon, L.I. 2002: Zebrafish as a cancer model system. Cancer Cell 1(3): 229-231
Sissener,N.H.; Johannessen,L.E.; Hevroy,E.M.; Wiik-Nielsen,C.R.; Berdal,K.G.; Nordgreen,A.; Hemre,G.I. 2010: Zebrafish as a model for investigating the safety of GM feed ingredients ; performance, stress response and uptake of dietary DNA sequences. British Journal of Nutrition 3(1): 3-15
Berman, J.; Hsu, K.; Look, A.T. 2003: Zebrafish as a model organism for blood diseases. British Journal of Haematology 123(4): 568-576
Mcgrath, P.; Fremgen, T.; Zhang, C.; Willett, C. 2003: Zebrafish as a predictive model for assessing toxicity of chemotherapeutics. Toxicological Sciences 72(S-1): 247
Parng, C.; Anderson, N.; Mcgrath, P. 2003: Zebrafish bioassays for assessing substance abuse. Toxicological Sciences 72(S-1): 247
Agaba, M.; Tocher, D.R.; Dickson, C.A.; Dick, J.R.; Teale, A.J. 2004: Zebrafish cDNA encoding multifunctional fatty acid elongase involved in production of eicosapentaenoic and docosahexaenoic acids. Marine Biotechnology (New York) 6(3): 251-261
Fang, P.K.; Solomon, K.; Zhuang, L.; Freeman, M.R.; Yelick, P.C. 2003: Zebrafish caveolin-1a and caveolin-1b Indispensable roles in embryo development. Developmental Biology 259(2): 530
Nambiar, R.M.; Henion, P.D. 2003: Zebrafish colgate-mediated inhibition of Wnt signaling is required for early dorso-ventral and neuroectoderm patterning. Developmental Biology 259(2): 498
Kikuchi, K.; Willoughby, J.; Wegner, J.; Westerfield, M. 2001: Zebrafish engrailed 1 specifies muscle identity. Development Growth and Differentiation 43(Suppl): S101
Rubin, D.A.; Juppner, H. 1999: Zebrafish express the common parathyroid hormone/parathyroid hormone-related peptide receptor and a novel receptor that is preferentially activated by mammalian and fugufish parathyroid hormone-related peptide. Journal of Biological Chemistry 274(40): 28185-28190
Chan, J.; Bayliss, P.E.; Whitehead, G.; Keating, M.; Wood, J.M.; Roberts, T.M. 2003: Zebrafish fin regeneration as a model system for adult angiogenesis and anti-angiogenic therapy. Developmental Biology 259(2): 534
Schulte Merker, Stefan 2000: Zebrafish functional genomics. Yeast 17(3): 232-234, 30 September
Heisenberg, C.Philipp.; Tada, M. 2002: Zebrafish gastrulation movements: bridging cell and developmental biology. Seminars in Cell and Developmental Biology 13(6): 471-479
Prince, V.E.; Mcclintock, J.M. 1999: Zebrafish hox genes and hindbrain patterning. American Zoologist 39(5): 89A
Jesuthasan, S. 2002: Zebrafish in the spotlight. Science 297(5586): 1484-1485
Ayaso, E.; Nolan, K.; Byrnes, L. 1999: Zebrafish insulin-like growth factor-I receptor cDNA cloning and expression studies during development. Journal of Fish Biology 55(Suppl A): 239
López-Muñoz, A.; Roca, F.J.; Sepulcre, M.ía.P.; Meseguer, J.é; Mulero, V. 2010: Zebrafish larvae are unable to mount a protective antiviral response against waterborne infection by spring viremia of carp virus. Developmental and Comparative Immunology 34(5): 546-552
Field, H.A.; Ober, E.A.; Verkade, H.; Dong, D.; Stainier, D.Y.R. 2003: Zebrafish liver and pancreas morphogenesis. FASEB Journal 17(4-5): Abstract 531
Mccollum, C.; Lane, M.E.len 2003: Zebrafish lmo4 coorthologs in embryonic development. Developmental Biology 259(2): 509
Moore, J.L.; Mohideen, M.; Breneman, C.; Cheng, K.C. 2003: Zebrafish loss of heterozygosity mutants and cancer. Proceedings of the American Association for Cancer Research 44: 1176
Jensen, A.M.; Westerfield, M. 2001: Zebrafish mosaic eyes gene is required for tight junction formation in the retinal pigmented epithelium. Developmental Biology 235(1): 181
Artinger, K.B.; Chitnis, A.B.; Driever, W.; Mercola, M. 1999: Zebrafish narrowminded is involved in the specification of neural crest and primary sensory neurons. Developmental Biology 210(1): 200
Erter, C.E.; Solnica Krezel, L.; Wright, C.V.E. 1999: Zebrafish nodal-related 2/Squint encodes an early acting mesendodermal inducer acting from the extraembryonic YSL. Developmental Biology 210(1): 230
Baier, H. 2000: Zebrafish on the move: towards a behavior-genetic analysis of vertebrate vision. Current Opinion in Neurobiology 10(4): 451-455
Eddins, D.; Cerutti, D.; Williams, P.; Linney, E.; Levin, E.D. 2010: Zebrafish provide a sensitive model of persisting neurobehavioral effects of developmental chlorpyrifos exposure: comparison with nicotine and pilocarpine effects and relationship to dopamine deficits. Neurotoxicology and Teratology 32(1): 99-108
Baraban, S.C.; Castro, P.A.; Smear, M.C.; Baier, H. 2001: Zebrafish seizures Behavioral and electrophysiologic properties. Epilepsia 42(Suppl 7): 224-225
Arduini, B.; Henion, P. 2003: Zebrafish touchtone is selectively required for neural crest-derived melanophore development. Developmental Biology 259(2): 578
Knaut, H.; Pelegri, F.; Bohmann, K.; Schwarz, H.; Nuesslein Volhard, C. 2000: Zebrafish vasa RNA but not its protein is a component of the germ plasm and segregates asymmetrically prior to germ-line specification. Developmental Biology 222(1): 224
Sapede, D. 2003: Zebrafish, a model for migration of cancer cells?. Medecine Sciences: M/S 19(8-9): 780-782
Chen, S.; Lin, B.-Z.; Baig, M.; Mitra, B.; Lopes, R.J.; Santos, A.ón.M.; Magee, D.A.; Azevedo, M.; Tarroso, P.; Sasazaki, S.; Ostrowski, S.; Mahgoub, O.; Chaudhuri, T.K.; Zhang, Y.-p.; Costa, V.ân.; Royo, L.J.; Goyache, F.él.; Luikart, G.; Boivin, N.; Fuller, D.Q.; Mannen, H.; Bradley, D.G.; Beja-Pereira, A. 2010: Zebu cattle are an exclusive legacy of the South Asia neolithic. Molecular Biology and Evolution 27(1): 1-6
Schaefer, A. 2004: Zehnder to become director of ETH domain. Environmental Science and Technology 38(11): 195A
Huang, S.; Zhou, Q.; Malloy, K.; Adams, W.; Voyles, D.; Anthony, J.; Kriz, A.; Luethy, M. 2001: Zein reduction in transgenic plants expressing antisense zein cDNAs. Plant Biology (Rockville) : 65
West, R.J.; Kenis, M.; Bourchier, R.S.; Smith, S.M.; Butt, G.W. 2002: Zeiraphera canadensis Mutuura and Freeman, spruce bud moth. Mason, P G , Reprint Author, Huber, J T 1981-2000: 279-283
Pavlyutkin, B.I. 2001: Zelkova and Celtis from the late miocene flora of Primorye. Botanicheskii Zhurnal (St Petersburg) 86(6): 113-122
Barbagallo, S. 2002: Zelkovaphis trinacriae, a new Eriosomatine aphid genus and species living on Zelkova in Sicily. Bollettino di Zoologia Agraria e di Bachicoltura 34(3): 281-301
Rizzo, C.; Dionisi Vici, C.; Van Grunsven, E.G.; Sabetta, G.; Wanders, R.J.A. 2000: Zellweger-like syndrome due to D-bifunctional protein deficiency; a diagnostic challenge with major implications. Journal of Inherited Metabolic Disease 23(Suppl 1): 249
Martin, K.J.; Charney, D.; Lindberg, J.; Soltanek, C.; Llach, F. 2000: ZemplarTM dosing based on initial levels of iPTH A safe and effective method of treating secondary hyperparathyroidism. Journal of the American Society of Nephrology 11(Program and Abstract Issue): 579A
Augustine, K. 2003: Zen and the art of teratogenicity screen development Applications of mechanistic problem solving to generation of tailored teratogenicity screens. Toxicological Sciences 72(S-1): 113
Islam, K.K.; Rustgi, V.K.; Kuo, P.C.; Plotkin, J.S.; Kim, K.; Johnson, L.B. 2000: Zenapax and effect on clinical outcome of hepatitis C post liver transplant. Gastroenterology 118(4 Suppl 2 Pt 1): AASLD A995
Lácha, J.; Símová, M.; Nosková, L.; Teplan, V.; Vítko, S. 2001: Zenapax versus OKT-3 prophylaxis in immunologically high-risk kidney transplant recipients. Transplantation Proceedings 33(3): 2273-2274
Bialecki, R.; Abbott, B.; Barthlow, H.; Caccese, R.; Stow, R.; Rumsey, W.; Wilson, C. 2000: Zeneca ZD4054, an orally active endothelin-A receptor antagonist, prevents chronic hypoxia-induced pulmonary hypertension in the rat. FASEB Journal 14(4): A124
Theisen, J.; Stein, H.J.; Bruecher, B.L.; Prentl, K.; Feussner, H.; Siewert, J.R.ediger 2002: Zenker diverticulum Cricopharyngeal myotomy with diverticulopexy versus diverticulectomy. Gastroenterology 123(1 Suppl): 35
Stein, H.J.; Bruecher, B.B.; Theisen, J.; Prentl, K.; Feussner, H.; Siewert, J.R. 2001: Zenkers diverticulum Cricopharyngeal myotomy with diverticulopexy versus diverticulectomy. Gastroenterology 120(5 Suppl 1): A 477
Evrard, S.; Le Moine, O.; Hassid, S.; Devière, J. 2003: Zenker's diverticulum: a new endoscopic treatment with a soft diverticuloscope. Gastrointestinal Endoscopy 58(1): 116-120
Alin Botoman, V.; Gokce, P.; Breno, S.; Vickers, D.; Astor, F.; Hanft, K.; Bonner, G.; Mcguire, D.; Zakko, W.; Hershey, B. 1999: Zenkers diverticulum-Another supra-esophageal complication of GERD? Endoscopy and pH testing safely provide helpful data. Gastroenterology 116(4 Part 2): A126-A127
Koehler, W. 2003: Zentralblatt fuer Bakteriologie 100 Years ago The search for typhoid bacilli in drinking and river waters. Ijmm International Journal of Medical Microbiology 293(6): 385-389
Koehler, M.; Koehler, W. 2003: Zentralblatt fuer Bakteriologie 100 Years ago Victor Babes and enzootic haemoglobinuria of cattle. IJMM International Journal of Medical Microbiology 293(4): 233-239
Koehler, W.; Koehler, M. 2003: Zentralblatt fuer Bakteriologie 100 years ago Plague and rats, the Plague of the Philistines, and What did our ancestors know about the role of rats in plague. IJMM International Journal of Medical Microbiology 293(5): 333-340
Rose, Jane Anne 2003: Zeolite bed leach septic system and method for wastewater treatment. Official Gazette of the United States Patent and Trademark Office Patents 1268(2)
Deckman, Harry William; Corcoran, Edward William; Mc Henry, James Alexander; Lai, Wenyih Frank; Czarnetzki, Lothar Ruediger; Wales, William Edward 1999: Zeolite containing composition with a selectivity enhancing coating. Official Gazette of the United States Patent and Trademark Office Patents 1227(3)
Ichikawa, S.; Tanaka, S.; Nakane, T.; Aizawa, M.; Sato, K.; Mizuno, T.; Chida, H. 2003: Zeolite membrane for dehydration of biomass alcohol Contribution to mitigation of global warming. Abstracts of Papers American Chemical Society 225(1-2): FUEL 232
Kralj,P.; Rychagov,S.; Kralj,P. 2010: Zeolites in volcanic-igneous hydrothermal systems a case study of Pauzhetka geothermal field and Oligocene Smrekovec volcanic complex. Environmental Earth Sciences: 5, 951-956
Svyatash, G.A.; Gerasev, A.D.; Lukanina, S.N.; Panin, L.E.; Celsi, G.; Aizman, R.I. 2000: Zeolites increase intestinal secretion in rats with chronic renal failure. Nephrology Dialysis Transplantation 15(9): A10
Taborsky, J. 1999: Zeolitic inhibition of biocatalysis. Official Gazette of the United States Patent and Trademark Office Patents 1225(2)
Gao, K.; Dashzeveg, D. 2000: Zephyrosauridion A replacement name for Zephyrosaurus GAO and DASHZEVEG 1999. Paläontologische Zeitschrift 74(3): 467
Irshaid, F.; Kulp, S.K.; Sugimoto, Y.; Lee, K.; Lin, Y.C. 1999: Zeranol stimulates estrogen-regulated gene expression in MCF-7 human breast cancer cells and normal human breast epithelial cells. Biology of Reproduction 60(Suppl 1): 234-235
Harvey, M.S. 2003: Zeriassa Pocock, 1897 Proposed precedence over Canentis Pavesi, 1897. Bulletin of Zoological Nomenclature 60(2): 117-118
Neureiter, D.; Lorenz, A.; Gillner, W.; Lindner, A.; Kirchner, T. 2002: Zero Effort Networks A useful and powerful tool for central desktop management and maintenance in a department of pathology?. Pathology Research and Practice 198(3): 225
Cull, L.J. 2003: Zero compression microkeratome cutting head assembly. Official Gazette of the United States Patent and Trademark Office Patents 1269(5)
Suzuki, M. 2003: Zero emission. Nippon Nogeikagaku Kaishi 77(1): 33-35
Yankah, V.V.; Akoh, C.C. 2001: Zero energy fat-like substances Olestra. Gunstone, Frank D , Reprint Author Structured and modified lipids: 511-536
Tobia, R.L.; Somerson, S.K. 2002: Zero flow pause during volume ventilation. Official Gazette of the United States Patent and Trademark Office Patents 1257(3)
Murer, L.; Zanon, G.F.; Andreetta, B.; Dall'amico, R.; Gamba, P.G.; Della Vella, M.; Visentin, T.; Zacchello, G. 1999: Zero hour renal biopsy in kidney transplanted children. Journal of the American Society of Nephrology 10(Program and Abstr. Issue): 739A
Friesen, C.L.H.ncock; Buth, K.J.; Macdougall, C.; Wood, J.R.; Stewart, K.; Hirsch, G.M.; Sullivan, J.A. 2000: Zero proximals Composite radial artery grafts. Canadian Journal of Cardiology 16(Suppl F): 122F-123F
Rodd, V.A.; Wells, J.; Price, M.; Rees, H.; Chow, L.; Webb, K.; Mcrae, K.; Kolstee, H.; Wile, J.; Collette, L.; Ivany, J.; Gordon, R.; Toner, P.; Karemangingo, C. 2003: Zero tillage on the dykelands Fact or fantasy. Canadian Journal of Plant Science 83(3): 577-578
Moskowitz, Harry; Laraque, Danielle; Et Al 2003: Zero tolerance for violence Parent and physician focus groups. Pediatric Research 53(4 Part 2): 195A
Bendahmane, A. 1999: Zero-background plasmid vector for BAC library construction. Biotechniques 26(2): 228-30 232
Cote, I.; Anglicheau, D.; Flamant, M.; Droz, D.; Thervet, E.; Janin, A.; Legendre, C. 2002: Zero-hour biopsy in renal transplantation A marginal help to choose the donor. Journal of the American Society of Nephrology 13(Program and Abstracts Issue): 190A
Wagner, A.; Patzelt, A.; Risse, A.; Angelkort, B. 2000: Zero-mortality under avoidance of dyselectrolytaemias and thromboembolic complications in diabetic ketoacidosis. Diabetologia 43(Suppl 1): A198
Bezemer, J.M.; Radersma, R.; Grijpma, D.W.; Dijkstra, P.J.; Feijen, J.; Van Blitterswijk, C.A. 2000: Zero-order release of lysozyme from poly /poly matrices. Journal of Controlled Release 64(1-3): 179-192
Katzhendler, I.; Friedman, M. 2001: Zero-order sustained release delivery system for carbamazephine derivatives. Official Gazette of the United States Patent and Trademark Office Patents 1251(1)
Katzhendler, I.; Friedman, M. 1999: Zero-order sustained release matrix tablet formulations of carbamazepine. Official Gazette of the United States Patent and Trademark Office Patents 1228(2)
Ding, M.; Schroeder, N.C.; Reimus, P.W. 2001: Zero-valent iron as a reducing getter for immobilization of technetium. Abstracts of Papers American Chemical Society 222(1-2): ENVR149
Lien, H.L.; Wilkin, R. 2003: Zero-valent iron for high-level arsenite removal. Abstracts of Papers American Chemical Society 226(1-2): ENVR 18
Mattoo, A.; Verma, R.S. 2000: Zeroing-in-on breakpoint susceptibility regions on chromosomes in breast carcinoma. Genetics in Medicine 2(1): 94
Banan, A.; Fields, J.Z.; Farhadi, A.; Zhang, L.; Keshavarzian, A. 2002: Zeta isoform of protein kinase C is a novel modulator of intestinal barrier integrity and cytoskeletal assembly and key in cellular protection. Gastroenterology 122(4 Suppl 1): A-275
Veltri, E.P. 2003: Zetia A new approach to the treatment of atherosclerosis. Abstracts of Papers American Chemical Society 225(1-2): MEDI 155
Behan Pelletier, V.M.; Eamer, B. 2003: Zetomimidae of North America. Smith, Ian M , Reprint Author An acarological tribute to David R Cook (From Yankee Springs to Wheeny Creek): 21-56
Hernandez, J.M.; Montes, F.A.gel 1999: Zeuxia sicardi Villeneuve, 1920 First record of endoparasithysm in Iberodorcadion Breuning, 1943. Entomologiste 55(1): 39-43
Sasidharan, N.; Rajesh, K.P.; Augustine, J. 1999: Zeuxine affinis Benth ex Hookf A new record for Peninsular India. Rheedea 9(2): 159-161, 31 December
Winter, J.N.; Inwards, D.; Erwin, W.; Wiseman, G.; Rademaker, A.; Patton, D.R.; Williams, S.; Tallman, M.; Mehta, J.; Singhal, S.; Micallef, I.; Multani, P.; Zimmer, M. 2002: Zevalin Dose-Escalation Followed by High-Dose BEAM and Autologous Peripheral Blood Progenitor Cell Transplant in Non-Hodgkins Lymphoma Early Outcome Results. Blood 100(11): Abstract No. 1597
Leigh, B.; Multani, P.S.; Grillo Lopez, A.J.; White, C.A. 2000: Zevalin radioimmunotherapy Clinical update. Journal of Immunotherapy 23(5): 590
Kornmehl, E.M.; Wiseman, G.A.; Sparks, R.B.; Leigh, B.R.; Erwin, W.D.; Silverman, D.A.; Podoloff, D.A.; Welsh, J.; Dunn, W.L.; Gordon, L.I.; Grillo Lopez, A.J.; White, C.A. 2000: Zevalin radioimmunotherapy for relapsed of refractory B-cell non-Hodgkins lymphoma Interim clinical and dosimetry findings support a weight-adjusted dosing schedule. International Journal of Radiation Oncology Biology Physics 48(3 Suppl): 237-238
Wiseman, G.; Witzig, T.; Flinn, I.; Gordon, L.; Emmanouilides, C.; Czuczman, M.; Saleh, M.; Cripe, L.; Multani, P.S.; Grillo Lopez, A.J.; White, C.A. 2000: Zevalin radioimmunotherapy is effective and safe without imaging and biodistribution dosimetry in patients with rituximab-refractory follicular lymphoma. Cancer Biotherapy and Radiopharmaceuticals 15(4): 408
Meredith, R.F.; Leigh, B.R.; Wiseman, G.A.; Kornmehl, E.M.; Raubitschek, A.A.; Welsh, J.S.; Levy, R.L.; Terry, L.N.; Zhang, C.; White, C.A. 2001: Zevalin radioimmunotherapy is effective for patients with bulky non-Hodgkins lymphoma. International Journal of Radiation Oncology Biology Physics 51(3 Suppl 1): 69-70
White, C.A.; Wiseman, G.A.; Witzig, T.E.; Gordon, L.I.; Leigh, B.; Grillo Lopez, A.J. 1999: Zevalin radioimmunotherapy of relapsed or refractory non-Hodgkins lymphoma. European Journal of Cancer 35(Suppl 5): S57
Saleh, M.; White, C.A.; Witzig, T.E.; Gordon, L.; Wiseman, G.A.; Emmanouilides, C.; Murray, J.L.; Lister, J.; Landin, R.; Multani, P.S. 2001: Zevalin radioimmunotherapy offers safe and effective therapy for relapsed or refractory, B cell non-Hodgkins lymphoma. European Journal of Cancer 37(Suppl 6): S35-S36
Czuczman, M.; Witzig, T.E.; Gaston, I.; Skikne, B.S.; Dimitrov, G.; Gordon, L.I.; Emmanouilides, C.; White, C.A. 2002: ZevalinTM Radioimmunotherapy Is Not Associated with an Increased Incidence of Secondary Myelodysplastic Syndrome or Acute Myelogenous Leukemia. Blood 100(11): Abstract No. 1386
Emmanouilides, C.; Witzig, T.E.; White, C.A.; Gordon, L.I.; Wiseman, G.A.; Murray, J.L.; Lister, J.; Multani, P.S. 2001: ZevalinTM radioimmunotherapy is associated with a low infection risk. Blood 98(11 Part 2): 227b-228b
Li, D.; Eng, F.; Friedman, S.L. 1999: Zf9 regulates cell proliferation and apoptosis in activated stellate cells and NIH 3T3 cells. Hepatology 30(4 Part 2): 393A
Darling, D.S.; Yen, G.; Zoeller, R.T.; Stearman, R.P. 2001: Zfhep transcription factor may influence neural cell differentiation. Developmental Biology 235(1): 218-219
Guo, J.; Dawson, M.R.; Beard, K.C.ristopher 2000: Zhailimeryx, a new lophiomerycid artiodactyl from the late middle Eocene of central China and the early evolution of ruminants. Journal of Mammalian Evolution 7(4): 239-258
Saez Llorens, X.; Nelson, R.P.Jr.; Emmanuel, P.; Wiznia, A.; Church, J.; Sleasman, J.; Van Dyke, R.; Richardson, C.G.; Rosko, C.; Cutrell, A.; Hetherington, S.V. 2000: ZiagenTM combined with 3TC and ZDV is safe and effective through 48 weeks in HIV-1 infected antiretroviral therapy-experienced children. Pediatric Research 47(4 Part 2): 275A
Van Dam, K.E. Oscar; Bastidas, A.M.S.; Denys, H.; Jadidizadeh, A.; Nik, S.A.; Tejpar, S.; Cassiman, J.J. 2003: Zic1 overexpression in desmoid tumors. Proceedings of the American Association for Cancer Research 44: 836
Aruga, J.; Toumonda, T.; Mikoshiba, K. 1999: Zic1 regulates proliferation of the dorsal neural progenitors in the mouse and chick spinal cord. Society for Neuroscience Abstracts 25(1-2): 526
Keller, M.; Jiang, D.; Chitnis, A. 2003: Zic2 and Zic3 proteins together regulate proneural and neural crest domains in zebrafish. Developmental Biology 259(2): 560
Ware, S.M.; Harutyunyan, K.G.; Belmont, J.W. 2003: Zic3 is critical for early embryonic patterning and the maintenance of symmetry during gastrulation. Developmental Biology 259(2): 494
Purandare, S.M.; Gebbia, M.; Bassi, M.T.; Kwan, K.M.; Vogel, H.; Behringer, R.; Casey, B. 2000: Zic3-deficient mice manifest defects in left-right axis development. American Journal of Human Genetics 67(4 Suppl 2): 173
Chmielinska, J.J.; Tejero Taldo, M.I.; Mak, I.T.; Weglicki, W.B. 2004: Zidovudine Treatment Promotes Upregulation of Endotoxin Receptor in the Rat. FASEB Journal 18(4-5): Abstract 817
Colebunders, R.; Coppieters, Y. 1999: Zidovudine against mother-to-child HIV transmission. Tropical Medicine and International Health: Tm and Ih 4(3): 237-238
Khatoon, A.; Khanani, A.; Ziyad, A.; Ali, S.; Shah, S. 2000: Zidovudine monotherapy and role of lady health visitors in prevention of HIV transmission from mothers to infants. AIDS 14(Suppl 4): S88
Zuccotti, G.V.; Ferraris, G.; Agostoni, C.; Rancilio, L.; Ravizza, M.; Bucceri, A.M.; Riva, E.; Marini, A. 1999: Zidovudine prophylaxis and perinatal HIV-1 transmission. Acta Paediatrica 88(11): 1298
Kumphitak, A.; Cawthorne, P.; Lakhonphol, S.; Kasi-Sedapan, S.; Sanaeha, S.; Unchit, N.; Wilson, D. 1999: Zidovudine to prevent mother-to-infant HIV transmission in developing countries: a view from Thailand. Tropical Medicine and International Health: Tm and Ih 4(3): 236-7; Author Reply 237-8
Chitnis, S.; Mondal, D.; Agrawal, K.C. 2002: Zidovudine treatment suppresses granulocyte-monocyte colony stimulating factor receptor type alpha gene expression in murine bone marrow cells. Life Sciences 71(8): 967-978
Delke, I.; Sanchez Ramos, L.; Mora, C.S.ayne 1999: Zidovudine use to reduce perinatal HIV-1 transmission Northeast Florida experience. American Journal of Obstetrics and Gynecology 180(1 Part 2): S81
Herb, R.A.; Wheeler, S.M.; Gallagher, G.E.; Coleman, R.G.; Shoolroy, A.K.; Magallanes, J.; Coast, J.R. 2002: Zidovudine-mediated neonatal diaphragm contractile dysfunction. Medicine and Science in Sports and Exercise 34(5 Suppl): S155
Adams, A.C.; Keefe, K.A. 1999: Zif268 expression induced by a low dose of eticlopride is dependent on NMDA receptors. Society for Neuroscience Abstracts 25(1-2): 1653
Davis, S.; Bozon, B.; Laroche, S.; Garel, S.; Charnay, P.; Jones, M.W.; Errington, M.L.; French, P.; Fine, A.; Bliss, T.V.P. 2000: Zif268 is required for the stabilisation of LTP in the dentate gyrus and for two forms of learning. European Journal of Neuroscience 12(Suppl 11): 248
Stefen, C. 2001: Zigzag Hunter-Schreger-bands revisited. Journal of Morphology 248(3): 288
Greenhalgh, D.G.; Palmieri, T.L. 2003: Zigzag seams for the prevention of scar bands after sheet split-thickness skin grafting. Surgery 133(5): 586-587
Wu, X.; Leong, A.B.; Dev, A. 1999: Zileuton, a 5-lipoxygenase inhibitor, increases platelet thromboxane A2 production in patients with asthma. JGIM 14(Suppl 2): 82
Dubé, L.M.; Swanson, L.J.; Awni, W. 1999: Zileuton, a leukotriene synthesis inhibitor in the management of chronic asthma. Clinical pharmacokinetics and safety. Clinical Reviews in Allergy and Immunology 17(1-2): 213-221
Chandiwana, S.; Gregson, S.; Gomo, E.; Marowa, E.W.; Matanhire, D. 2001: Zimbabwean capacity for HIV/AIDS research Current situation and new demands. Zimbabwe Science News 35(1-2): 43-50
Gomez Reyes, B.; Yatsimirsky, A.K. 2002: Zinc -catalyzed cleavage of unactivated amide and peptide bonds by hydroxylamine. Abstracts of Papers American Chemical Society 224(1-2): INOR 149
Carter, P.H.; Gardella, T.J. 2001: Zinc -mediated enhancement of the agonist activity of histidine-substituted parathyroid hormone analogues. Biochimica et Biophysica Acta 1538(2-3): 290-304, 23 April
Carter, P.H.; Gardella, T.J. 1999: Zinc -mediated enhancement of the cAMP signaling activity of histidine-substituted PTH analogs. Journal of Bone and Mineral Research 14(Suppl 1): S543
Zhu, Y.G.; Smith, S.E.; Smith, F.A. 2001: Zinc -phosphorus interactions in two cultivars of spring wheat differing in P uptake efficiency. Annals of Botany 88(5): 941-945
Rink, L. 1999: Zinc Activation and inhibition of the immune system by a bivalent cation. Immunology 98(Suppl 1): 74
Sandstead, H.H. 2000: Zinc Growth, development, and function. Journal of Nutrition 130(2 Suppl): 347S-349S
Kudalkar, P.R.; Brody, J.; Buccholtz, M.S. 2002: Zinc Induced Copper Deficiency Anemia and Leucopenia A Case Report. Blood 100(11): Abstract No. 3519
Kang, H.W.; Freake, H.C. 2004: Zinc Inhibits the Induction of S14 mRNA by T3 in Primary Rat Hepatocytes. FASEB Journal 18(4-5): Abstract 103
Kankapurker, S.; Kim, Y.; Hentges, D. 2004: Zinc Intake of Indian Children Aged 11-15 years in Hyderabad, India. FASEB Journal 18(4-5): Abstract 588
Odashima, M.; Otaka, M.; Wada, I.; Konishi, N.; Pacheco, I.I.; Sato, T.; Kato, S.; Watanabe, S. 2000: Zinc L-carnosine prevented acetic acid induced colonic lesion by induction of a 72-kDa heat shock protein and inhibition of NF-kappaB activation in rat colonic mucosa. Gastroenterology 118(4 Suppl 2 Pt 1): AGA A825
Karandikar, S.; Dong, Q.; Joshi Barve, S.; Mcclain, C.; Barve, S. 2004: Zinc Prevents Ceramide Induced JNK activation, Caspase-3 Activity and Apoptosis in Jurkat T lymphocytes. FASEB Journal 18(4-5): Abstract 366
Kim, S.C.; Griffin, I.J.; Abrams, S.A. 2000: Zinc absorption and excretion are abnormal in children with Crohns disease. JPGN 31(Suppl 2): S77
Tran, C.D.; Hambidge, M.K.; Miller, L.V.; Sian, L.; Westcott, J.E.; Krebs, N.K. 2004: Zinc absorption as a function of dose of Zn sulfate in aqueous solution. FASEB Journal 18(4-5): Abstract 98
Lonnerdal, B.; Mendoza, C.; Brown, K.H.; Raboy, V.; Rutger, J.Neil; Cook, A. 2003: Zinc absorption from low phytate genotypes of corn, barley and rice assessed in a suckling rat pup model. FASEB Journal 17(4-5): Abstract 424
Ruz, M.; Codoceo, J.; Krebs, N.F.; Lei, S.; Westcott, J.L.; Hambidge, K.M. 2000: Zinc absorption from micronutrient fortified dried cow milk. FASEB Journal 14(4): A205
Hambidge, K.M.; Huffer, J.W.; Raboy, V.E.; Dorsch, J.A.; Westcott, J.; Adams, C.; Krebs, N.F. 2001: Zinc absorption from two low phytic acid corns. FASEB Journal 15(4): A402
Muyssen, B.T.A.; Janssen, C.R. 1999: Zinc acclimatization and deficiency of freshwater organisms Consequences for their sensitivity towards zinc. Mededelingen van de Faculteit Landbouwwetenschappen - Rijksuniversiteit Gent 64(4): 39-42
Siegel, R.J.; Buckingham, N.J.; James, C.M.; Williams, W.J.; Lightfoot, D.R. 1999: Zinc accumulation in soil bacteria. Abstracts of the General Meeting of the American Society for Microbiology 99: 474
Fakler, T.M.; Ward, T.L.; Kuhl, H.J. 2002: Zinc amino acid complexes Zn improve layer production and egg quality. Poultry Science 81(Suppl 1): 120
Suphioglu, C.; Sadli, N.; Coonan, D.; Kumar, L.; De Mel, D.; Lesheim, J.; Sinclair, A.J.; Ackland, L. 2010: Zinc and DHA have opposing effects on the expression levels of histones H3 and H4 in human neuronal cells. British Journal of Nutrition 103(3): 344-351
Bermudez, V.; Lukiw, W.J.; Bazan, N.G. 2001: Zinc and aluminum induce NF-kappaB-DNA binding and COX-2 gene expression in human neural progenitor cells in primary culture. Journal of Neurochemistry 78(Suppl 1): 193
Gershanik, E.F.; Lukiw, W.J.; Ottlecz, A.; Lambrou, G.N.; Bazan, N.G. 2001: Zinc and aluminum induce hypoxia-inducible-factor-1- -DNA binding and VEGF gene expression in primate choroidal endothelium. IOVS Investigative Ophthalmology and Visual Science 42(4): S242
Grześ, I.M. 2010: Zinc and cadmium regulation efficiency in three ant species originating from a metal pollution gradient. Bulletin of Environmental Contamination and Toxicology 84(1): 61-65
Tsuchiya, D.; Weinstein, P.R.; Kayama, T. 2002: Zinc and cerebral ischemia. Yamagata Medical Journal 20(2): 115-118
E.A.i Hellal, M.; Ghorbel, H.; Bousnina, M.; Boujlel, K.; Dachraoui, M.; Labidi, A.; Ndif, M.; Amamou, M.; Hedhili, A. 2003: Zinc and copper concentrations in seawater and algae of the Tunisian coast. Toxicology Letters (Shannon) 144(Suppl 1): s170
Dozier, W.A.IIi; Davis, A.J.; Freeman, M.E.; Ward, T.L. 2002: Zinc and copper excretion of broiler chicks fed gradient concentrations of zinc and copper from three different sources. Poultry Science 81(Suppl 1): 141-142
Frederickson, C.J.; Maret, W.; Cuajungco, M.P. 2004: Zinc and excitotoxic brain injury: a new model. Neuroscientist: a Review Journal Bringing Neurobiology Neurology and Psychiatry 10(1): 18-25
Soto Alvarez, M.L.; Alvarez Nava, F.; Rojas Atencio, A.E.; Gonzalez, R.; Caizalez, J.; Granadillo, V.; Fernandez, D.; Ocando, A.; Vasquez, A.; Herrera, J.; Fulcado, W. 2001: Zinc and immune function in Down syndrome. American Journal of Human Genetics 69(4 Suppl): 284
Lovelady, C.A.; Kinsella, T.; Fuller, C.J.; Taylor, M.L.; Geigerman, C. 2002: Zinc and immune status of exercising lactating women. FASEB Journal 16(4): A660
Mocchegiani, E.; Muzzioli, M.; Giacconi, R. 2000: Zinc and immunoresistance to infection in aging: new biological tools. Trends in Pharmacological Sciences 21(6): 205-208
Mocchegiani, E.; Muzzioli, M.; Giacconi, R. 1999: Zinc and infections in aging Parallelism with HIV. European Journal of Clinical Investigation 29(Suppl 1): 57
Christian, P.; West, K.P.Jr.; Khatry, S.K.; Yamini, S.; Micaiah, E.; Shrestha, S.B. 2000: Zinc and iron interaction among pregnant Nepali women A reassuring story. FASEB Journal 14(4): A510
Penland, J.G.; Egger, N.G.; Ramanujam, V.M.S.; Dayal, H.H.; Sandstead, H.H. 2002: Zinc and iron repletion improves cognitive function of mildly deficient women. FASEB Journal 16(5): A974-A975
Chebassier, N.; Leroy, S.; Tenaud, I.; Knol, A.C.; Dreno, B. 2000: Zinc and matrix metalloproteinases expression by keratinocytes cultured in vitro. Journal of Investigative Dermatology 115(3): 547
Ebadi, M.; Shavali, S.; Sharma, S.; El Refaey, H. 2002: Zinc and metallothionein protects dopaminergic neurons against rotenone- and salsolinol-induced neurotoxicity. FASEB Journal 16(5): A948
Zago, M.P.; Mackenzie, G.G.; Keen, C.L.; Adamo, A.M.; Clegg, M.S.; Oteiza, P.I. 2001: Zinc and the activation of AP-1 in human neuroblastoma cells. Cellular and Molecular Neurobiology 21(2): 172
Iqbal, S.; Good, R.A.; Nelson, R.P.Jr 1999: Zinc and thymulin deficiency in a child with Kabuki syndrome. Journal of Allergy and Clinical Immunology 103(1 Part 2): S147
Rahman, M.M.; Wahed, M.A.; Fuchs, G.J.; Baqui, A.H.; Vermund, S.H.; Alvarez, J.O. 2000: Zinc and vitamin A interaction in children Effect on vitamin A nutriture and morbidity. FASEB Journal 14(4): A797
Kaneda, M.; Ishii, K.; Akagi, T.; Hashikawa, T. 2003: Zinc as a neurotransmitter in the rat retina. Kaneko, Akimichi The neural basis of early vision: 139-142
Wapnir, R.A.; Wingertzahn, M.A.; Rehman, K.U.; Altaf, W. 2001: Zinc as a potential antidiarrheal agent Its role on nitric oxide metabolism. FASEB Journal 15(4): A402
Allington, C.; Ross, G.M.; Shamovsky, I.L.; Riopelle, R.J. 1999: Zinc attenuates the pro-apoptotic effects of NGF in retinal neurons. Society for Neuroscience Abstracts 25(1-2): 761
Reiterer, G.; Meerarani, P.; Toborek, M.; Hennig, B. 2003: Zinc augments the antiinflammatory properties of PPAR agonists in vascular endothelial cells. FASEB Journal 17(4-5): Abstract 189
Schlegel, P.; Nys, Y.; Jondreville, C. 2010: Zinc availability and digestive zinc solubility in piglets and broilers fed diets varying in their phytate contents, phytase activity and supplemented zinc source. Animal: An International Journal of Animal Bioscience 4(2): 200-209
Chukwuma,M.C.; Eshett,E.T.; Onweremadu,E.U.; Okon,M.A. 2010: Zinc availability in relation to selected soil properties in a crude oil polluted eutric tropofluvent. International Journal Of Environmental Science And Technology: 2, 261-270
Lecka Czernik, Beata 1999: Zinc binding LIM protein S2-6. Official Gazette of the United States Patent and Trademark Office Patents 1226(4)
Bergman, T.; Palmberg, C.; Jörnvall, H.; Auld, D.S.; Vallee, B.L. 1999: Zinc binding characteristics of the synthetic peptide corresponding to the structural zinc site of horse liver alcohol dehydrogenase. Advances in Experimental Medicine and Biology 463: 339-342
Guszczynski, T.; Kapust, R.B.; Waugh, D.S.; Copeland, T.D. 2001: Zinc binding to SET protein A capillary electrophoresis study. Amino Acids 21(1): 6
Penner Hahn, J.E.; Tobin, D.; Matthews, R.G.; Fierke, C.A.; Peariso, K.; Grahame, D.A.; Garrow, T.A. 2003: Zinc catalyzed alkyl-transfer enzymes. Journal of Inorganic Biochemistry 96(1): 58, 15 July
Dineley, K.E.; Richards, L.L.; Votyakova, T.V.; Reynolds, I.J. 2002: Zinc causes loss of membrane potential and alters production of reactive oxygen species in isolated brain mitochondria. Journal of Neurochemistry 81(Suppl 1): 104
Sciaudone, M.P.; Schaller, M.A.; Freake, H.C. 2001: Zinc chelation inhibits the activity of the transfected growth hormone promoter in GH3 cells. FASEB Journal 15(4): A257
Brooks, N.A.; Brooks, L.S. 2003: Zinc chloride unit dose packaging, applicator, and method of use in treating cancer and other skin diseases. Official Gazette of the United States Patent and Trademark Office Patents 1270(1)
Ryles, C.W.; Williams, D.R.; Ziemkiewicz, A.G.; Urbaez, J.A. 2003: Zinc citrate beads in oral compositions. Official Gazette of the United States Patent and Trademark Office Patents 1272(3)
Prego, R.; Cobelo Garcia, A. 2003: Zinc concentrations in the water column influenced by the oil spill in the vicinity of the Prestige shipwreck. Ciencias Marinas 29(1): 103-108
Smith, J.B. 2002: Zinc containing compositions for anti-viral use. Official Gazette of the United States Patent and Trademark Office Patents 1264(1)
Yu, D.; Parikh, R.M.; Pozzi, C.; Kohut, B. 2001: Zinc containing dentifrice compositions. Official Gazette of the United States Patent and Trademark Office Patents 1245(4)
Miller, R.T.; Martasek, P.; Roman, L.J.; Masters, B.S.S. 1999: Zinc content of E coli-expressed isoforms of nitric oxide synthase Enzymatic activity and effect of pterin. FASEB Journal 13(7): A1564
Kennedy, W.R.; Czajka Narins, D.M.; Imrhan, V.; Radcliffe, J.D. 1999: Zinc content of selected retail cuts of beef and pork. FASEB Journal 13(5 Part 2): A887
Strang, C.J.; Rocha, C.; Kanjilwar, K.; Covarrubias, M.; Pfafinger, P. 2004: Zinc coordination and redox chemistry in voltage gated potassium channels. Biophysical Journal 86(1): 11a
Burdette, S.C.; Woodroofe, C.C.; Lippard, S.J. 2002: Zinc coordination compounds that emit light Applications in metalloneurochemistry. Abstracts of Papers American Chemical Society 224(1-2): INOR 582
Mackenzie, G.G.; Zago, M.; Keen, C.L.; Clegg, M.S.; Oteiza, P.I. 2001: Zinc deficiency affects NF-kappaB nuclear binding activity in neuroblastoma cells. Journal of Neurochemistry 78(Suppl 1): 142
Kurihara, N.; Yanagisawa, H.; Sato, M.; Wada, O. 2000: Zinc deficiency aggravates hypertension in genetic and acquired hypertensive rats. Journal of the American Society of Nephrology 11(Program and Abstract Issue): 336A
Chou, S.S.; Clegg, M.S.; Momma, T.Y.; Niles, B.J.; Keen, C.L. 2003: Zinc deficiency alters protein kinase C metabolism. FASEB Journal 17(4-5): Abstract 189
Moore, J.B.; Blanchard, R.K.; Cousins, R.J. 2001: Zinc deficiency alters specific mRNA abundance in murine thymus prior to alterations in thymocyte populations. FASEB Journal 15(5): A736
Falkiewicz, B.; Dabrowska, E.; Lukasiak, J.; Cajzer, D.; Jabłońska-Kaszewska, I. 2000: Zinc deficiency and normal contents of magnesium and calcium in metabolic X syndrome patients as assessed by the analysis of hair element concentrations. Biofactors 11(1-2): 139-141
Iotova, P.; Koteva, A.; Ionova, D.; Tzachev, K. 1999: Zinc deficiency and peripheral neuropathy in patients on RDT. Nephrology Dialysis Transplantation 14(9): A216
Muyssen, B.; Janssen, C.R. 2000: Zinc deficiency and toxicity in multi-generation acclimation experiments with Daphnia magna Shifts in zinc tolerance. Comparative Biochemistry and Physiology Part A Molecular and Integrative Physiology 126A(Suppl 1): S108
Zachar, P.; Mazariegos, M.; Mena, I.; Brown, S.; Seagle, H.; Krebs, N.; Solomons, N.W.; Hambidge, M. 2000: Zinc deficiency at the millennium The study of a semi-rural Guatemalan community. FASEB Journal 14(4): A510
Shay, N.F.; Ezzatkhah, M.; Prisecaru, V.I.; Mangian, H.F. 1999: Zinc deficiency does not affect self-selection of dietary protein in 2-choice macronutrient preference tests using albumin or purified amino acids. FASEB Journal 13(4 Part 1): A215
Kojima, A.; Ichikawa, H.; Takami, N.; Kawada, N.; Nishiguchi, S.; Matsui Yuasa, I. 2000: Zinc deficiency enhances collagen expression in hepatic stellate cells. Hepatology 32(4 Pt 2): 505A
Cui, L.; Wang, L.; Alshatwi, A.; Schoene, N.W.; Han, C.T.; Fanzo, J.C.; Lei, K.Y. 2004: Zinc deficiency enhances p53 accumulation and phoshorylation by p38 kinase but alters p53 transactivation in HepG2 cells. FASEB Journal 18(4-5): Abstract 103
Cui, L.B.; Wang, L.R.; Schoene, N.W.; Alshatwi, A.; Han, C.T.; Lei, K.Y. 2003: Zinc deficiency impairs p53 transactivation activity in HepG2 cells. FASEB Journal 17(4-5): Abstract 712
Binnebösel, M.; Grommes, J.; Koenen, B.; Junge, K.; Klink, C.D.; Stumpf, M.; Ottinger, A.P.; Schumpelick, V.; Klinge, U.; Krones, C.J. 2010: Zinc deficiency impairs wound healing of colon anastomosis in rats. International Journal of Colorectal Disease 25(2): 251-257
Clegg, M.S.; Jankowski Hennig, M.A.; Hong, H.; Daston, G.P.; Keen, C.L. 2001: Zinc deficiency in 3T3 mouse fibroblasts tiggers both apoptotic and necrotic cell death pathways. FASEB Journal 15(5): A966
Clegg, M.S.; Keen, C.L.; Jankowski, M.A.; Hong, H.; Daston, G.P. 2001: Zinc deficiency in 3t3 mouse fibroblasts results in both apoptotic and necrotic cell death. FASEB Journal 15(5): A966
Clegg, M.S.; Momma, T.Y.; Chou, S.S.; Hanna, L.A.; Keen, C.L. 2002: Zinc deficiency in Swiss 3t3 cells results in abnormal oxidative, glutathione, and mineral metabolism with concomitant apoptotic and necrotic cell death. Molecular Biology of the Cell 13(Suppl): 441a-442a
NaeemRaza; Khan,D.A. 2010: Zinc deficiency in patients with persistent viral warts. Journal of the College of Physicians and Surgeons--Pakistan JCPSP 20(2): 83-86
Rodriguez, D.S. 2003: Zinc deficiency in pecan Multidisciplinary case study for upper division/graduate level mineral nutrition course. HortScience 38(5): 697
Evans, S.A.; Alshingiti, A.M.; Zeidan, N.T.; Vanlandingham, J.W.; Parsons, A.D.; Gagnon, S.P.; Williams, T.D.; Chambers, J.B. 2003: Zinc deficiency induces anxiety-like behaviors in rats. FASEB Journal 17(4-5): Abstract 189
Reiterer, G.; Meerarani, P.; Macdonald, R.; Browning, J.D.Jr.; Toborek, M.; Hennig, B. 2004: Zinc deficiency induces proatherogenic signaling pathways. FASEB Journal 18(4-5): Abstract 366
Nadruz, W.; Bellinazzi, V.R.; Carvalheira, J.é B.C. 2002: Zinc deficiency leading to intractable vomiting. Archives of Internal Medicine 162(20): 2376-2377
Yeiser, E.C.; Levenson, C.W. 2001: Zinc deficiency promotes zinc accumulation and apoptosis following brain injury. FASEB Journal 15(4): A402
Kurihara, N.; Yanagisawa, H.; Sato, M.; Moridaira, K.; Wada, O. 1999: Zinc deficiency reduces renal blood flow without changing blood pressure. Journal of the American Society of Nephrology 10(Program and Abstr. Issue): 382A
Cui, L.; Cousins, R.J. 2002: Zinc deficiency tissue-specifically modulates progenitor cell associated with universal upregulation of integrin-beta1 expression. FASEB Journal 16(4): A651
Jankowski Hennig, M.A.; Clegg, M.S.; Daston, G.P.; Rogers, J.M.; Keen, C.L. 1999: Zinc deficiency-induced cell death in rat embryos is associated with increased caspase 3-like activity. FASEB Journal 13(4 Part 1): A570
Lopez, V.; Keen, C.L.; Lanoue, L. 2003: Zinc deficiency-induced developmental heart defects in rat fetuses result in part from impaired cardiac neural crest cells metabolism. FASEB Journal 17(4-5): Abstract 189
Elsas, S.M.; Hazany, S.; Mody, I. 2003: Zinc delays the development of seizures in a kindling model of epilepsy. Neurology 60(5 Suppl 1): A72
Lanoue, L.; Lopez, V.; Keen, C.L. 2003: Zinc depletion disrupts rat cardiac neural crest cells cytoskeletal organization and is associated with poor morphology and motility and increased cell death. Birth Defects Research 68(3): 230
Lopez, V.; Lanoue, L.; Keen, C.L. 2002: Zinc depletion impairs rat cardiac neural crest cells viability and motility and induces oxidative stress in vitro. Teratology 65(6): 295
Chu, Y.; Mouat, M.F.; Coffield, J.A.; Grider, A. 2002: Zinc deprivation affects cognitive behavior assessed by the Morris Water Maze. FASEB Journal 16(5): A976
Meerarani, P.; Toborek, M.; Hennig, B. 2000: Zinc down-regulates SAPK/JNK cascade and apoptosis of endothelial cells. FASEB Journal 14(4): A195
De Plazas, S. Fiszer; Gravielle, M.C.; De Novara, A. Mitridate 1999: Zinc effect on GABAA receptor complex during avian CNS development. Society for Neuroscience Abstracts 25(1-2): 1228
Carlson, G.C.; Lee, C.J.; Coulter, D.A. 2002: Zinc facilitates hyperexcitability in the hippocampus of epileptic rats. Epilepsia 43(Suppl 7): 138
Barbas, C.F. 2003: Zinc finger binding domains for GNN. Official Gazette of the United States Patent and Trademark Office Patents 1273(4)
Lima, W.F.; Crooke, S.T.; Manoharan, M. 2002: Zinc finger peptide cleavage of nucleic acids. Official Gazette of the United States Patent and Trademark Office Patents 1257(1)
Choo, Y.; Isalan, M.; Patel, S.D.; Balasubramanian, S.; Liu, X. 2002: Zinc finger polypeptides capable of binding DNA quadruplexes. Official Gazette of the United States Patent and Trademark Office Patents 1265(2)
Barbas, C.F.; Gottesfeld, J.M.; Wright, P.E. 2000: Zinc finger protein derivatives and methods therefor. Official Gazette of the United States Patent and Trademark Office Patents 1239(5)
Caltagarone, J.; Jordan Sciutto, K.; Dragich, J.; Bowser, R. 1999: Zinc finger proteins FAC1 and MAZ A novel transcription factor interaction in neurodegeneration. Society for Neuroscience Abstracts 25(1-2): 833
Laity, J.H.; Lee, B.M.; Wright, P.E. 2001: Zinc finger proteins: new insights into structural and functional diversity. Current Opinion in Structural Biology 11(1): 39-46
Krempler, A.; Brenig, B. 2000: Zinc finger proteins in skeletal muscle growth and differentiation. Comparative Biochemistry and Physiology Part A Molecular and Integrative Physiology 126A(Suppl 1): S83
Kuchen, S.; Pap, T.; Kunzler, P.; Gay, R.E.; Gay, S.; Aicher, W.K. 1999: Zinc finger transcription factor Egr-1 induces the expression of collagenase inhibitor TIMP-1 in rheumatoid arthritis synovial fibroblasts. Arthritis and Rheumatism 42(9 Suppl): S247
Kapoor, S.; Takatsuji, H. 2001: Zinc finger transcription factors play essential roles in pollen development in petunia. Plant and Cell Physiology 42(Suppl): s29
Brown, N.C.; Barnes, M.H.; Wright, G.E. 2002: Zinc finger-reactive antimicrobial compounds. Official Gazette of the United States Patent and Trademark Office Patents 1260(2)
Baldwin, M.A.; Whittal, R.; Scott, G.; Semyonov, J.; Burlingame, A.; Benz, C.C. 1999: Zinc fingers in the estrogen receptor DNA-binding domain exhibit asymmetric susceptibility to oxidant stress. Breast Cancer Research and Treatment 57(1): 97
Reigo, A.; Metspalu, A. 2002: Zinc fingers on short arm of chromosome 9 pointing to lymphocytes. European Journal of Human Genetics 10(Suppl 1): 167
Vodyanitskii,Yu.N. 2010: Zinc forms in soils. Eurasian Soil Science: 3, 269-277
Penland, J.G.; Lukaski, H.C.; Gray, J.S. 2003: Zinc fortification and cognitive and psychosocial function in young adolescents. FASEB Journal 17(4-5): Abstract 678
Prom-u-thai,C.; Rerkasem,B.; Cakmak,I.; HuangLongBin 2010: Zinc fortification of whole rice grain through parboiling process. Food Chemistry 2010(3): 858-863. Ef
Khaled, S.; Brun, J.F.; Cassanas, G.; Bardet, L.; Mercier, J.; Prefaut, C. 1999: Zinc gluconate and acetate in vitro decrease red cell aggregability. Biorheology 36(1-2): 107-108
Lei, S.; Krebs, N.F.; Westcott, J.; Li, F.; Li, T.; Miller, L.; Hambidge, K.M. 2000: Zinc homeostasis during early lactation in women with low dietary Zn intakes. FASEB Journal 14(4): A476
Tran, C.; Butler, R.N.; Howarth, G.S. 1999: Zinc in combination with a growth factor extract derived from bovine whey promotes recovery from methotrexate-induced small bowel damage in rats. Gastroenterology 116(4 Part 2): A940
Wetzel, S.; Kullig, U.; Porst, H.; Klemm, M. 2000: Zinc in patients with chronic hepatitis C. Gastroenterology 118(4 Suppl 2 Pt 2): AASLD A149
Revy, P.S.; Jondreville, C.; Dourmad, J.Y.; Nys, Y. 2003: Zinc in pig nutrition The essential trace element and potential adverse effect on environment. Productions Animales 16(1): 3-18
Ugarte, M.; Osborne, N.N. 2001: Zinc in the retina. Progress in Neurobiology 64(3): 219-249
Woodworth, B.A.; Zhang, S.; Tamashiro, E.; Bhargave, G.; Palmer, J.N.; Cohen, N.A. 2010: Zinc increases ciliary beat frequency in a calcium-dependent manner. American Journal of Rhinology and Allergy 24(1): 6-10
Tran, C.D.; Huynh, H.; Campbell, F.; Coyle, P.; Butler, R.N. 2001: Zinc induces a metal-binding protein in Helicobacter pylori. Gastroenterology 120(5 Suppl 1): A 655
Feng, P.; Liang, J.Y.; Franklin, R.B.; Costello, L.C. 1999: Zinc induces mitochondrial apoptogenesis in prostatic carcinoma cells. European Urology 36(5): 543
Perez, M.J.; Cederbaum, A.I. 2002: Zinc induction of metallothionein protects against arachidonic acid toxicity in CYP2E1-expressing HepG2 cells. Free Radical Biology and Medicine 33(Suppl 2): S338
Feng, P.; Franklin, R.B.; Costello, L.C. 2004: Zinc induction of mitochondrial apoptogenesis in prostate cells. Biophysical Journal 86(1): 516a
Bobilya, D.J.; Mcclung, J.P.; Volak, L.; Lehmann, H.M. 1999: Zinc influences the binding affinity of albumin to endothelial cells. FASEB Journal 13(4 Part 1): A569
Lambert, J.C.; Zhou, Z.; Kang, Y.J. 2002: Zinc inhibition of ethanol-induced liver apoptosis is independent of metallothionein protection. FASEB Journal 16(5): A945
Uzzo, R.G.; Horwitz, E.M.; Pollack, A.; Greenberg, R.E.; Kolenko, V.M. 2003: Zinc inhibits NFKB activation and sensitizes prostate cancer cells to apoptotic death via cytotoxic agents. Journal of Urology 169(4 Suppl): 155
Kilari, S.; Pullakhandam, R.; Nair, K.M. 2010: Zinc inhibits oxidative stress-induced iron signaling and apoptosis in Caco-2 cells. Free Radical Biology and Medicine 48(7): 961-968
Taylor, C.; Contreras, M.; Gates, G.; Droke, E.; Smith, B. 2001: Zinc intake and bone mineral density in runners vs nonrunners. FASEB Journal 15(5): A977
Scrimgeour, A.G.; Marchitelli, L.J.; Volpe, S.L.; Young, A.J. 2004: Zinc intake influences bone elastic modulus in Sprague-Dawley rats. FASEB Journal 18(4-5): Abstract 366
Aburto, N.J.; Laing, E.; Hardy, K.; Modlesky, C.; Lewis, R. 2003: Zinc intake is positively correlated with bone parameters in prepubertal girls. FASEB Journal 17(4-5): Abstract 682
Kim, S.H.; Commisso, J.; Keen, C.L. 2004: Zinc intakes and major food sources of zinc among elementary schoolchildren in remote rural and urban areas in Korea. FASEB Journal 18(4-5): Abstract 366
Colvin, R.A. 1999: Zinc ion transport measured using rat cortical neurons in primary culture. Society for Neuroscience Abstracts 25(1-2): 2209
Fliss, H. 2002: Zinc ionophores as anti-apoptotic agents. Official Gazette of the United States Patent and Trademark Office Patents 1259(3)
Fliss, H. 2002: Zinc ionophores as therapeutic agents. Official Gazette of the United States Patent and Trademark Office Patents 1265(3)
Mckechnie, K.; Varghese, J.J.; Miller, D.J. 1999: Zinc ions can evoke tension and also accelerate and potentiate rigor tension, mimicking Ca2+, in isolated chemically skinned rat ventricle trabeculae. Journal of Physiology (Cambridge) 521P: 36P
Singer, E.A.; Scholze, P.; Gether, U.; Sitte, H.H. 2001: Zinc is a potent modulator of reverse transport mediated by the dopamine transporter, but not the norepinephrine transporter. Naunyn-Schmiedeberg's Archives of Pharmacology 363(4): R11
Macdonald, R.S.; Browning, J.D.; O'dell, B.L. 2001: Zinc is required for IGF-I stimulated calcium uptake in Swiss 3T3 fibroblasts. FASEB Journal 15(4): A402
Mukherjea, R.; Shames, D.M.; Woodhouse, L.R.; Pinna, K.; King, J.C. 2003: Zinc kinetics in healthy men during marginal zinc depletion and repletion. FASEB Journal 17(4-5): Abstract 424
Wastney, M.E.; House, W.A. 1999: Zinc kinetics in metallothionein-knockout mice. FASEB Journal 13(4 Part 1): A214
Sazinsky, M.H.; Ehrenfeld, J.; Jaffe, E.K.; Scarrow, R.C. 1999: Zinc ligation in the active site of human and bovine porphobilinogen synthases. Journal of Inorganic Biochemistry 74(1-4): 287
Li, C.J.; Venkatraman, S. 2000: Zinc mediated and palladium catalyzed carbon-carbon bond formation in air and water. Abstracts of Papers American Chemical Society 220(Part 2): ORGN 543
Griffin, I.J.; Kim, S.C.; Abrams, S.A. 2001: Zinc metabolism and zinc kinetics in children with stable Crohns disease. FASEB Journal 15(5): A965
Huybrechts, R.; Macours, N.; Hens, K.; Vandingenen, A. 2001: Zinc metalloprotease action in insect follicular developement. American Zoologist 41(6): 1645
Schnabel, R.C.; Kakoullis, J.; Delo, D.; Guida, W.C. 2002: Zinc metalloprotease model systems. Abstracts of Papers American Chemical Society 223(1-2): CHED 402
Schnabel, R.C.; Guida, W.C.; Kakoullis, J.J.; Thomas, T. 2003: Zinc metalloprotease model systems Synthesis and characterization of a series of zinc bis and tris imidazole complexes. Abstracts of Papers American Chemical Society 225(1-2): INOR 185
Suwa, H.; Legendre, P. 1999: Zinc modifies glycinergic inhibitory synaptic activity in the zebrafish hindbrain. Society for Neuroscience Abstracts 25(1-2): 1248
Craig, T.A.; Benson, L.M.; Naylor, S.; Kumar, R. 2000: Zinc modulates the assembly/disassembly of vitamin D receptor and retinoid X receptor alpha transcriptional complexes. Journal of Bone and Mineral Research 15(Suppl 1): S200
Ueno, T.; Akaike, N.; Nabekura, J. 1999: Zinc modulation of P2X receptor mediated response on dorsal vagal motoneuron. Society for Neuroscience Abstracts 25(1-2): 460
Mcmahon, D.G.; Zhang, D.Q.; Lu, C. 1999: Zinc modulation of glutamate receptors on retinal horizontal cells. IOVS Investigative Ophthalmology and Visual Science 40(4): S241
Laube, B.; Betz, H. 1999: Zinc modulation of inhibitory glycinergic synaptic currents. Society for Neuroscience Abstracts 25(1-2): 1248
Zeitlin, B.D.; Rainsford, K.D. 1999: Zinc monoglycerolate and zinc salt cellular uptake profile in vitro determined by plasma mass spectrometry. Inflammopharmacology 7(3): 336-337
Haurani, F. 2003: Zinc negative modulation of ferritin. Blood 102(11): 3b
Sheline, C.T.; Behrens, M.M.; Choi, D.W. 1999: Zinc neurotoxicity A possible role for NAD+ depletion. Society for Neuroscience Abstracts 25(1-2): 1523
Nezu, R.; Kobayashi, H.; Takagi, Y.; Okada, A. 1999: Zinc nutrition and requirement in patients with gut failure receiving long-term parenteral nutrition. Journal of Parenteral and Enteral Nutrition 23(5 Suppl): S164
Strong, D.C.; Johnston, K.E.; Kitchin, E.M.; Morgan, S.L.; Tamura, T. 2001: Zinc nutriture in women with osteoporosis who receive calcium supplements. FASEB Journal 15(5): A977
Broom, L.J.; Miller, H.M.; Kerr, K.G.; Toplis, P. 2002: Zinc oxide and avilamycin enhance pig performance. Journal of Dairy Science 85(Suppl 1): 390
Tapley, C.A. Maria; Lyth, P.L.; Harper, I.M. 1999: Zinc oxide dispersions. Official Gazette of the United States Patent and Trademark Office Patents 1223(4)
Kuroda, A.; Waki, Y.; Shimomura, M. 2000: Zinc oxide powder with suppressed activity and cosmetic preparation. Official Gazette of the United States Patent and Trademark Office Patents 1239(3)
Lohani, S.P.; Casavant, M.J.; Ekins, B.R.; Walson, P.D.; Wolowich, W.R. 2000: Zinc phosphide poisoning A retrospective study of 21 cases. Journal of Toxicology. Clinical Toxicology 38(5): 515
Hernandez Olivares, C.P.; Rosiles Martinez, R.; Masri Daba, M.; Perez Thomsen, J.L. 2002: Zinc phosphide poisoning in a mare. Veterinaria Mexico 33(3): 343-346
Sas Nowosielska, A.; Kucharski, R.; Malkowski, E.; Pogrzeba, M. 1999: Zinc plant toxicity in process of lead and cadmium phytoextraction. Acta Physiologiae Plantarum 21(3 Suppl): 70
Berg, K.; Bolt, G.; Andersen, H.; Owen, T.C. 2001: Zinc potentiates the anti viral action of human interferon-alpha ten-fold. Journal of Interferon and Cytokine Research 24(Suppl 1): S 123
Gould, T.W.; Prevette, D.; Milligan, C.; Oppenheim, R.W. 1999: Zinc prevents avian embryonic lumbar spinal motoneurons from undergoing axotomy-induced but not naturally occurring cell death by a caspase-3 independent mechanism. Society for Neuroscience Abstracts 25(1-2): 1532
Muratori, M.; Spinelli, S.; Forti, G. 2000: Zinc prevents spontaneous DNA fragmentation in human ejaculated spermatozoa. Journal of Endocrinological Investigation 23(6 Suppl): 45
Mobashery, S. 2002: Zinc proteases and their involvement in remodeling of the extracellular matrix. Abstracts of Papers American Chemical Society 224(1-2): MEDI 422
Badescu, L.I.; Fratu, C.; Mustata, T.; Rosca, M.; Bohotin, C.; Badescu, M. 2000: Zinc protecting effect on vascular glication in experimental diabetes mellitus. Journal of Submicroscopic Cytology and Pathology 32(3): 368
Lesser, K.; Schoel, S.; Widness, J.; Kling, P. 2003: Zinc protoporphyrin heme ratios in infants born to women with diabetes. American Journal of Obstetrics and Gynecology 189(6 Suppl): S106
Seiberg, M.; Filippi, M.; Ricklis, A.; Iotsova, V.; Lin, C.B. 2003: Zinc pyrithione delays hair growth and follicular melanogenesis. Journal of Investigative Dermatology 121(1): 0784
Upadhyay, R.; Panda, S.K. 2010: Zinc reduces copper toxicity induced oxidative stress by promoting antioxidant defense in freshly grown aquatic duckweed Spirodela polyrhiza L. Journal of Hazardous Materials 175(1-3): 1081-1084
Kohara, K.; Oketani, M.; Tuvdendorj, D.; Maeda, M.; Komorizono, Y.; Ishibashi, K.; Arima, T. 2002: Zinc regulate hepatoma cell apoptosis through modulation of the redox potential including glutathione system. Hepatology 36(4 Part 2): 474A
Badescu, M.V.; Paduraru, I.; Colev, V.; Rosca, M.; Ciocoiu, M.; Badescu, V. 2000: Zinc regulates platelet-vascular wall interaction in diabetes mellitus. Journal of Submicroscopic Cytology and Pathology 32(3): 351
Juang, Horng Heng 2002: Zinc regulates the putative metal-response element of human mitochondrial aconitase gene in the human prostate carcinoma cells. Biology of Reproduction 66(Suppl 1): 242
Alshingiti, A.M.; Vanlandingham, J.W.; Fitch, C.A.; Blakemore, L.J.; Trombley, P.Q.; Levenson, C.W. 2002: Zinc regulation of rat olfactory bulb NPY. FASEB Journal 16(4): A650-A651
Korichneva, I.L.; Yue, Y.; Boutjdir, M. 2004: Zinc release from PKC isoforms is a determinant of the molecular redox status alterations during myocardial ischemia and reperfusion. Biophysical Journal 86(1): 228a
Mellor, J.R.; Vogt, K.E.; Tong, G.; Nicoll, R.A. 2000: Zinc release modulates synaptic NMDA receptor function at hippocampal mossy fibre synapses. Journal of Physiology (Cambridge) (523P): 186P-187P
Hillman, J.L.; Lal, P.; Shah, P. 1999: Zinc ring protein. Official Gazette of the United States Patent and Trademark Office Patents 1229(1)
Stéphan, F.; Revuz, J. 2004: Zinc salts in dermatology. Annales de Dermatologie et de Venereologie 131(5): 455-460
Levy, M.; Bray, T. 2003: Zinc sensitive genes in the mouse brain Results from a high-density oligonucleotide microarray analysis. Free Radical Biology and Medicine 35(Suppl 1): S69
Quinta Ferreira, M.E.; Matias, C.M.; Arif, M.; Dionisio, J.C. 2000: Zinc signals associated with mossy fiber LTP in area CA3 of the hippocampus. European Journal of Neuroscience 12(Suppl 11): 459
Yilmaz,K.; Saltali,K.; Guzel,E.U.; Dikici,H. 2010: Zinc sorption characteristics of soils in predominant smectite, illite and kaolinite clay minerals. Asian Journal Of Chemistry: 2, 1487-1494
Reyhanitabar,A.; Ardalan,M.; Gilkes,R.J.; Savaghebi,G. 2010: Zinc sorption characteristics of some selected calcareous soils of Iran. Journal Of Agricultural Science And Technology: 1, 99-110
Peltier, E.; Gaillard, J.F.ancois 2000: Zinc speciation and availability in an impacted wetland system. Abstracts of Papers American Chemical Society 220(Part 1): ENVR 306
Vasile, G.D.; Nicolau, M.; Vlădescu, L. 2010: Zinc speciation in sediments from a polluted river, as an estimate of its bioaccesibility. Environmental Monitoring and Assessment 160(1-4): 71-81
Grider, A.; Mouat, M.F.; Bobilya, D.J. 2002: Zinc status affects protein expression in bovine pulmonary artery endothelial cells. FASEB Journal 16(4): A651
Mohr, C.M.; Volpe, S.L. 2003: Zinc status and thyroid hormone function. Medicine and Science in Sports and Exercise 35(5 Suppl): S325
Colomb, V.; Landry, C.; Huart, B.; Lamor, M.; Goulet, O.; Ricour, C.; Corriol, O. 2000: Zinc status in children on long term parenteral nutrition. JPGN 31(Suppl 2): S24
Yoon, J.S.; Lee, I.; Yoon, J.; Park, J.; Lee, J. 2003: Zinc status, glycemic control and anti-oxidative capacity in diabetes mellitus patients. FASEB Journal 17(4-5): Abstract 196
Gibbs, S. 2003: Zinc sulphate for viral warts. British Journal of Dermatology 148(5): 1082-1083
Slobodan, K.; Vukcevic, V.; Dapcevic, B. 2001: Zinc sulphate treatment for pain relief in patients with acute intermitent porphyria. Journal of Hepatology 34(Suppl 1): 219
Black, M.M.; Sazawal, S.; Khosla, S.; Black, R.E. 2000: Zinc supplementation among children born 2500 grams promotes motor development. Pediatric Research 47(4 Part 2): 176A
Khaled, M.A.; Mahalanabis, D.; Jana, S.; Chowdhury, A.; Bhattacharya, M.; Chakrabarty, M.K.; Haque, K.M.; Das, K.P. 2001: Zinc supplementation and lipid peroxidation in children with measles and pneumonia. FASEB Journal 15(4): A610
Matson, A.; Wright, M.; Oliver, A.; King, N.; Woodrow, G.; Handley, R.; Dye, L.; Blundell, J.; Brownjohn, A.; Turney, J. 2001: Zinc supplementation at conventional doses does not improve the disturbance of taste perception in haemodialysis patients. Journal of the American Society of Nephrology 12(Program and Abstract Issue): 338A
Osendarp, S.J.M.; Van Raaij, J.M.A.; Baqui, A.H.; Fuchs, G.J. 1999: Zinc supplementation during pregnancy in Bangladeshi urban poor and infant growth and morbidity during first 6 months of life. FASEB Journal 13(4 Part 1): A207
Osendarp, S.J.M.; Baqui, A.H.; Santosham, M.; Black, R.E.; Fuchs, G.J. 2000: Zinc supplementation during the first 6 months of life and impact on growth and morbidity of Bangladeshi infants in urban slums. FASEB Journal 14(4): A561
Black, R.E. 1999: Zinc supplementation effects on diarrhea and pneumonia - A pooled analysis of randomized controlled trials. FASEB Journal 13(5 Part 2): A872
Arifeen, S.E.; Bresee, J.S.; Black, R.E.; Azim, T.; Yunus, M.; Baqui, A.H.; Wahed, M.A.; Glass, R.I. 2002: Zinc supplementation enhances the immune response to the rotavirus vaccine. FASEB Journal 16(4): A226
Taneja, S.; Strand, T.A.; Sommerfelt, H.; Bahl, R.; Bhandari, N. 2010: Zinc supplementation for four months does not affect growth in young north Indian children. Journal of Nutrition 140(3): 630-634
Mathew, J.L. 2010: Zinc supplementation for prevention or treatment of childhood pneumonia: a systematic review of randomized controlled trials. Indian Pediatrics 47(1): 61-66
Egger, N.; Sandstead, H.; Penland, J.; Alcock, N.; Plotkin, R.; Rocco, C.; Daval, H.; Zavaleta, A. 1999: Zinc supplementation improves growth in Mexican-American children. FASEB Journal 13(4 Part 1): A246
Hershkovitz, E.; Printzman, L.; Segev, Y.; Levy, J.; Phillip, M. 1999: Zinc supplementation increases the level of serum insulin-like growth factor-I but does not promote growth in infants with nonorganic failure to thrive. Hormone Research 52(4): 200-204
Esparza Gonzalez, B.P.; Nino Fong, R.; Fuentealba, I.; Cherian, M. 2003: Zinc supplementation may decrease hepatic copper accumulation in LEC rat A model of Wilsons disease. Toxicological Sciences 72(S-1): 402
Mahalanabis, D.; Chwdhury, A.; Jana, S.; Bhattacharya, M.K.; Chakrabarty, M.K.; Wahed, M.A.; Khaled, M.A. 2001: Zinc supplementation of children suffering from measles with pneumonia Effect on diseases severity. FASEB Journal 15(5): A1094
Nishida, T.; Ohata, S.; Kusumoto, C.; Mochida, S.; Nakada, J.; Inagaki, Y.; Ohta, Y.; Matsura, T. 2010: Zinc Supplementation with Polaprezinc Protects Mouse Hepatocytes against Acetaminophen-Induced Toxicity via Induction of Heat Shock Protein 70. Journal of Clinical Biochemistry and Nutrition 46(1): 43-51
Gazaryan, I.G.; Schedrina, V.; Klyachko, N.; Efimov, A.; Thorneley, R.N.F.; Brown, A.M. 2002: Zinc switch in pig heart lipoamide dehydrogenase Steady-state and transient kinetic studies. Abstracts of Papers American Chemical Society 224(1-2): BIOL 97
Cuajungco, M.P.; Faget, K.Y. 2003: Zinc takes the center stage Its paradoxical role in Alzheimers disease. Brain Research Reviews 41(1): 44-56
Hoogenraad, T.U. 2004: Zinc therapy for the treatment of Wilsons disease in the Netherlands. No To Hattatsu 36: S75
Lee, T.S.ien Judy; Trinh, C.; Carson, D.; Jacob, M.; Tam, C. 2002: Zinc to copper ratios of hepatic tissue and plasma in pre-hibernating, hibernating, post-hinbernating golden mantled ground squirrels. FASEB Journal 16(5): A991
Lee, T.S. Judy; Trinh, C.; Lin, W.W.; Carson, D.E.; Jacob, M.; Tam, C.F. 2003: Zinc to protein ratios of liver tissues in pre-hibernating, hibernating, post-hibernating male and female golden mantled ground squirrels. FASEB Journal 17(4-5): Abstract 189
Paopairochanakorn, C.; Warfield, S.; White, S. 2001: Zinc toxicity associated with massive coin ingestion. Journal of Toxicology. Clinical Toxicology 39(5): 553
Lee, J.M.; Zipfel, G.J.; Park, K.H.; He, Y.Y.; Hsu, C.Y.; Choi, D.W. 1999: Zinc toxicity in mild focal ischemic brain injury. Society for Neuroscience Abstracts 25(1-2): 1847
Agnew, D.W.; Barbiers, R.B.; Poppenga, R.H.; Watson, G.L. 1999: Zinc toxicosis in a captive striped hyena (Hyaena hyaena). Journal of Zoo and Wildlife Medicine: Official Publication of the American Association of Zoo Veterinarians 30(3): 431-434
Bobilya, D.J.; Brothwell, B.B. 2002: Zinc transport by brain capillary endothelial cells during moderate zinc deficiency and zinc excess. FASEB Journal 16(5): A975
Hogstrand, C. 2000: Zinc transport in fish. Comparative Biochemistry and Physiology Part A Molecular and Integrative Physiology 126A(Suppl 1): S69
Kelleher, S.L.; Lonnerdal, B. 2002: Zinc transport in mouse mammary epithelial cells is regulated by lactogenic hormones and zinc through effects on ZnT1 and ZnT4. FASEB Journal 16(4): A617
Song, Y.; Elias, V.; Wong, C.P.; Scrimgeour, A.G.; Ho, E. 2010: Zinc transporter expression profiles in the rat prostate following alterations in dietary zinc. Biometals: An International Journal on the Role of Metal Ions in Biology Biochemistry and Medicine 23(1): 51-58
Guaiume, E.A.; Broomhead, J.N.; Butkeraitis, P.; Ledoux, D.R.; Veum, T.L.; Raboy, V.; Zyla, K. 2002: Zinc utilization is improved in broiler chicks fed a diet containing low phytic acid barley. Poultry Science 81(Suppl 1): 142
Tenaud, I.; Leroy, S.; Chebassier, N.; Dreno, B. 2000: Zinc, copper and manganese enhanced keratinocyte migration through a functional modulation of keratinocyte integrins. Experimental Dermatology 9(6): 407-416
Olives, J.P.; Tscherning, C.; Broue, P.; Dedieu, G.; Ghisolfi, J. 2000: Zinc, copper and selenium concentrations in digestive secretions in children. JPGN 31(Suppl 2): S88-S89
Penland, J.; Sandstead, H.; Egger, N.; Dayal, H.; Alcock, N.; Plotkin, R.; Rocco, C.; Zavaleta, A. 1999: Zinc, iron and micronutrient supplementation effects on cognitive and psychomotor function of Mexican-American school children. FASEB Journal 13(5 Part 2): A921
Rubio Armendariz, C.; Gonzalez Weller, D.; Alonso Marrero, S.; Revert Girones, C.; Hardisson, D.L.T.rre, A. 2004: Zinc, magnesium, copper, selenium and chromium Nutrition and supplementation. Alimentaria 41(353): 37-44
Kiss, Z.; Huang, J.S.; She, Q.B.; Crilly, K.S.; Mukherjee, J.J. 1999: Zinc- and calcium-dependent co-mitogenic effects of ethanol. FASEB Journal 13(5 Part 2): A882
Brysk, M.M.; Lei, G.; Arany, I.; Tyring, S.K. 1999: Zinc-01alpha2-glycoprotein modulates the adhesion and proliferation of oral tumor cells. Journal of Investigative Dermatology 112(4): 621
Katsel, P.L.; Schwarz, T.E.; Tagliente, T.M.; Craddock Royal, B.D.; Patel, N.D.; Maayani, S. 2002: Zinc-Linked Inhibition of Adenylyl Cyclase Slows down Platelet Deaggregation Mediated by TXA2 Receptor Activation. Blood 100(11): Abstract No. 3728
Russell, S.T.; Zimmerman, T.; Domin, B.; Tisdale, M.J. 2003: Zinc-alpha2-glycoprotein In vitro and in vivo lipolytic activity. International Journal of Obesity 27(Suppl 1): S63
Brown, A.M.; Welsh, T.; Dowling, C.W. 2001: Zinc-ammonium phosphate fertilizers. Official Gazette of the United States Patent and Trademark Office Patents 1252(4)
Modak, S.; Sampath, L.; Caraos, L. 1999: Zinc-based antiirritant creams. Official Gazette of the United States Patent and Trademark Office Patents 1228(3)
Suzuki, H.; Mori, M.; Seto, K.; Watanabe, C.; Kai, A.; Hasada, I.; Suematsu, M.; Miura, S.; Ishii, H. 2000: Zinc-carnosine chelate compound, polaprezinc, attenuates Hpylori-induced gastric mucosal leukocyte activation in Mongolian gerbils An intravital observation of gastric microcirculation. Gastroenterology 118(4 Suppl 2 Pt 1): AGA A746
Chung, K.W.; Om, A.S. 2000: Zinc-deficiency affects neural aromatization of androgens and estrogen receptors in rats. FASEB Journal 14(4): A777
Estevez, A.G.; Crow, J.P.; Sampson, J.B.; Zhuang, Y.; Barbeito, L.; Beckman, J.S. 1999: Zinc-deficient ALS mutant SOD induces motor neuron apoptosis by an oxidative mechanism requiring nitric oxide Role of nitrotyrosine. Society for Neuroscience Abstracts 25(1-2): 46
Ermilov, V.; Ermilova, I.; Fischer, K.A.; Beckman, J.S. 2002: Zinc-deficient diet accelerates motor neuron disease in ALS-mutant G93A SOD transgenic mice. Free Radical Biology and Medicine 33(Suppl 2): S432-S433
Borda, E.J.; Sigurdsson, S.T. 2003: Zinc-dependent cleavage in the hammerhead ribozyme Characterization and use in studying the mechanisms of inhibition by antibiotics. Abstracts of Papers American Chemical Society 226(1-2): BIOL 77
Zheng, F.; Conn, P.J.; Traynelis, S.F. 1999: Zinc-dependent desensitization of NR1/NR2A receptors. Society for Neuroscience Abstracts 25(1-2): 24
Cox, E.H.; McLendon, G.L. 2000: Zinc-dependent protein folding. Current Opinion in Chemical Biology 4(2): 162-165
Akamuma, G.; Nanamiya, H.; Natori, Y.; Murayama, R.; Kosono, S.; Kudo, T.; Kobayashi, K.; Ogasawara, N.; Park, S.M.; Ochi, K.; Kawamura, F. 2003: Zinc-dependent regulatory mechanism contorolling for alternation of two-types of L31protein in Bacillus subtilis. Genes and Genetic Systems 78(6): 490
Yoon, Y.H.; Hyun, H.J.; Sohn, J.H.; Ha, D.W.; Koh, J.Y. 2000: Zinc-depletion-induced apoptosis of cultured human pigment epithelial cells. IOVS Investigative Ophthalmology and Visual Science 41(4): S413
Korichneva, I.L.; Hoyos, B.; Levi, E.; Chua, R.; Hammerling, U. 2003: Zinc-finger domain as a dynamic switch in classical and oxidative activation of protein kinase C. FASEB Journal 17(4-5): Abstract 852
Conrad, E.M.; Ahearn, G.A. 2004: Zinc-histidine co-transport by a PEPT-1-like transport system in lobster intestine. FASEB Journal 18(4-5): Abstract 460
Manzerra, P.; Behrens, M.M.; Canzoniero, L.M.T.; Sheline, C.; Kerchner, G.; Heidinger, V.; Choi, D.W. 1999: Zinc-induced MAPK activation enhances subsequent neuronal death. Society for Neuroscience Abstracts 25(1-2): 2204
Pandey, N.R.; Srivastava, A.K. 2003: Zinc-induced activation of ERK 1/2 and Akt signaling is independent of insulin receptor protein tyrosine kinase in Chinese hamster ovary cells. FASEB Journal 17(4-5): Abstract 130
Kransler, K.M.; Villalobos, A.R. 2003: Zinc-induced changes in HSP70 distribution and actin cytoskeleton in cultured cultured choroid plexus. Toxicological Sciences 72(S-1): 69-70
Rice, L.; Sweeney, C.A.; Kram, D.E.; Briggs, R.W.; Buszko, M. 2002: Zinc-induced changes in prostate cancer cell growth and viability. Journal of Nutrition 132(11 Suppl): 3543S
Behrens, M.M.; Manzerra, P.; Heidinger, V.; Choi, D.W. 1999: Zinc-induced intracellular signaling pathways Activation of PLCgamma, Akt/PKB, and MAPK. Society for Neuroscience Abstracts 25(1-2): 2203
Suh, S.W.; Danscher, G.; Jo, S.M.; Motamedi, M.; Frederickson, C.J. 1999: Zinc-induced neuronal death after traumatic spinal cord injury. Society for Neuroscience Abstracts 25(1-2): 1332
Zercher, C.K.; Lai, S.J.; Hilgenkamp, R.K. 2001: Zinc-mediated chain extension reactions Studies in alpha-functionalization. Abstracts of Papers American Chemical Society 221(1-2): ORGN 678
Han, G.S.; Johnston, C.N.; Carman, G.M. 2001: Zinc-mediated regulation of yeast DGPP phosphatase and localization in vacuolar membranes. FASEB Journal 15(4): A15
Toncheva, E.; Metcheva, R.; Topashka Ancheva, M. 1999: Zinc-metalloenzyme activities in intestinal epithelium of mice treated with polymetallic industrial dust. Dokladi na B"lgarskata Akademiya na Naukite 52(5-6): 111-114
Demoor, J.M.; Collins, O.M.; Koropatnick, D.J.mes 2000: Zinc-metallothionein levels and enhanced hormonal signaling in mouse cells exposed to ZnCl2, HgCl2 and heat shock. Proceedings of the American Association for Cancer Research 41: 27-28
Newsome, D.A.; Tate, D. 2003: Zinc-monocysteine complex and method of using zinc-cysteine complexes. Official Gazette of the United States Patent and Trademark Office Patents 1272(1)
Roncucci, Gabrio; Dei, Donat; De Filippis, Maria Paol; Fantetti, Li; Masini, Ilari; Cosimelli, Barbar; Jori, Giulio 1999: Zinc-phthalocyanines and corresponding conjugates, their preparation and use in photodynamic therapy and as diagnostic agents. Official Gazette of the United States Patent and Trademark Office Patents 1227(2)
Keates, A.C.; Keates, S.; Warny, M.; Kelly, C.P. 2000: Zinc-requiring nuclear factors of 105 kDa regulate basal ENA-78 gene expression in Caco-2 colonic epithelial cells. Gastroenterology 118(4 Suppl 2 Pt 1): A97
Sohnle, P.G.; Hunter, M.J.; Hahn, B.L.; Chazin, W.J. 2000: Zinc-reversible antimicrobial activity of recombinant migration inhibitory factor related proteins 8 and 14. Clinical Infectious Diseases 31(1): 264
Reynolds, I.J.; Kress, G.J.; Dineley, K.E. 1999: Zinc-sensitive dyes overestimate the duration of i increases in cultured forebrain neurons. Society for Neuroscience Abstracts 25(1-2): 599
Worthington, M.T.; Luo, R.; Browne, L.; Berg, C.L. 1999: Zinc-substituted porphyrin as a fluorescent probe of cellular heme metabolism. Gastroenterology 116(4 Part 2): A586
Santana, G.; D'oliveira Junior, A.; Santos Junior, A.F.; Barral, A.; Barral Netto, M.; Van Weyenbergh, J. 2000: Zinc/copper imbalance as a marker for immunodeficiency in human leishmaniasis?. Memorias do Instituto Oswaldo Cruz 95(Suppl 2): 206-207
Wouters, M.A.; Husain, A. 1999: Zincin and exopeptidase superfamilies of zinc metalloproteases share a common fold. Biophysical Journal 76(1 Part 2): A180
Tang, X.H.; Mezei, O.; Shay, N.F. 2001: Zincs insulin-like effect depends on cell signaling and actin filament reorganization. FASEB Journal 15(4): A399
Taniguchi, H.; Amemiya, T. 2001: Zincs role in apoptosis in the rat cornea. IOVS Investigative Ophthalmology and Visual Science 42(4): S890
Aicher, W.K.; Weis Klemm, M.; Alexander, D.; Kuchen, S.; Gay, S. 2001: Zink-finger transcription factor Egr-1 represses its own transcription but induces transcription of tissue inhibitor of matrix-metalloproteinase-1. FASEB Journal 15(5): A882
Burdette, S.; Lippard, S. 2002: Zinpyr and rhodafluor sensors Fluorescence-based probes for Zn2+. Abstracts of Papers American Chemical Society 224(1-2): INOR 6
Altschuld, R.A.; Dumitrescu, C.; Thirugnanam, M.; Mccune, S.A.; Hohl, C.M. 2000: Zinterol versus isoproterenol effects on mechanical restitution of rat hearts. Biophysical Journal 78(1 Part 2): 372A
Lackey, G.; Alsop, J.; Albertson, T. 2002: Ziprasidone A 12-month review of acute overdoses. Journal of Toxicology. Clinical Toxicology 40(5): 686
Madrigal, M.; Diez, T.; Cano, M. 2003: Ziprasidone A promising alternative in the treatment of schizophrenia. Methods and Findings in Experimental and Clinical Pharmacology 25(Suppl A): 79
Gunasekara, N.S.; Spencer, C.M.; Keating, G.M. 2002: Ziprasidone: a review of its use in schizophrenia and schizoaffective disorder. Drugs 62(8): 1217-1251
Arenson, D.R.; Busch, F.R.; Hausberger, A.G.; Rasadi, B. 2000: Ziprasidone formulations. Official Gazette of the United States Patent and Trademark Office Patents 1240(3)
Weisler, R.H.; Dunn, J.; English, P. 2003: Ziprasidone in adjunctive treatment of acute bipolar mania A randomized, double-blind placebo-controlled Trial. European Neuropsychopharmacology 13(Suppl 4): S344-S345
Segal, S.; Riesenberg, R.A.; Ice, K.; English, P. 2003: Ziprasidone in mania A 21-day randomized, double-blind, placebo controlled Trial. European Neuropsychopharmacology 13(Suppl 4): S345-S346
Taylor, D. 2003: Ziprasidone in the management of schizophrenia : the QT interval issue in context. Cns Drugs 17(6): 423-430
Schooler, N.R.; Murray, S.; Siu, C.O.; Romano, S.J. 2003: Ziprasidone negative symptom efficacy in long-term clinical trials. European Neuropsychopharmacology 13(Suppl 4): S301
Addington, D.; Pantelis, C.; Dineen, M.; Benattia, I.; Romano, S.J.; Murray, S. 2003: Ziprasidone versus risperidone in schizophrenia 52 Weeks comparative data. European Neuropsychopharmacology 13(Suppl 4): S299
Schooler, N.R.; Siu, C. 2000: Ziprasidones effect on anxiety in a group of outpatients with stable schizophrenia. European Neuropsychopharmacology 10(Suppl 3): S288
Fromtling, R.A. 2000: ZiracinTM Everninomicin antibiotic. Drugs of the Future 25(4): 360-368
Reddy, C.V.; Mahesh, M.; Raju, P.V.K.; Babu, T.R.; Reddy, V.V.N. 2002: Zirconium chloride catalyzed one-pot synthesis of 3,4-dihydropyrimidin-2 -ones. Tetrahedron Letters 43(14): 2657-2659, 1 April
Taylor, R.E.; Ciavarri, J.P.; Hearn, B.R. 1999: Zirconium-mediated allylations A diastereoselective approach to the myriaporones. Abstracts of Papers American Chemical Society 218(1-2): ORGN 591
Gladko, V.V.; Masyukova, S.A.; Pomerantsev, O.N. 2002: Zitrolid in therapy of urogenital chlamydiasis. Vestnik Dermatologii i Venerologii 6: 42-43
Arndt, S.K.; Clifford, S.C.; Popp, M. 2001: Ziziphus A multipurpose fruit tree for arid regions. Breckle, Siegmar-W , Veste, Maik , Wucherer, Walter Sustainable land use in deserts 388-399
Forestan, C.; Meda, S.; Varotto, S. 2010: ZmPIN1-mediated auxin transport is related to cellular differentiation during maize embryogenesis and endosperm development. Plant Physiology 152(3): 1373-1390
Masuda, H.; Tokairin, I.; Jitsukawa, K.; Einaga, H. 1999: Zn -OH complexes with tripodal tetradentate ligands as a functional model of carbonic anhydrase. Journal of Inorganic Biochemistry 74(1-4): 225
Knipp, M.; Braun, O.; Gehrig, P.M.; Sack, R.; Vasak, M. 2003: Zn -free dimethylargininase-1 is inhibited upon specific Cys-S-nitrosylation. Journal of Biological Chemistry 278(5): 3410-3416
Lim, Y.nsook; Quan, Ning; Bray, Tammy 2002: Zn affects early inflammatory phase of cutaneous wound healing. Free Radical Biology and Medicine 33(Suppl 2): S332
Thapalia, A.; Borrok, D.M.; Van Metre, P.C.; Musgrove, M.; Landa, E.R. 2010: Zn and Cu isotopes as tracers of anthropogenic contamination in a sediment core from an urban lake. Environmental Science and Technology 44(5): 1544-1550
Mai, K.; Tan, B. 2000: Zn and Fe in the forms of methionine chelation or sulphates as sources of dietary minerals for juvenile abalone, Haliotis discus hannai Ino. Journal of Shellfish Research 19(1): 536-537
Sato, M.; Yanagisawa, H.; Wada, O. 2001: Zn deficiency may develop genetic hypertension through a fall in the activity of Cu/Zn-SOD. Journal of the American Society of Nephrology 12(Program and Abstract Issue): 472A
Brown, A.M.; Kristal, B.S.; Effron, M.S.; Sheu, R.K.F.; Blass, J.P.; Cooper, A.J.L. 1999: Zn++ inhibits mitochondrial respiration and is potent inhibitor of the alpha-ketoglutarate dehydrogenase complex. Society for Neuroscience Abstracts 25(1-2): 1847
Kumar, A.P.; Chang, A.; Macleod, M.C. 1999: Zn-finger DNA-binding domain is not sufficient for molecular hijacking mediated by Sp1. Proceedings of the American Association for Cancer Research 40: 129-130
Miller, R.; Martasek, P.; Raman, C.; Poulos, T.; Masters, B.S. 1999: Zn-tetrathiolate as the metal center in all three isoforms of nitric oxide synthase expressed in E coli. Acta Physiologica Scandinavica 167(Suppl 645): 6
RusmidahAli; AbuBakar,W.A.W.; TeckLeeKin 2010: Zn/ZnO/TiO2 and Al/Al2O3/TiO2 photocatalysts for the degradation of cypermethrin. Modern Applied Science: 1, 59-67
Weiss, J.H.; Sensi, S.L.; Koh, J.Y. 2000: Zn(2+): a novel ionic mediator of neural injury in brain disease. Trends in Pharmacological Sciences 21(10): 395-401
Ahearn, G.A.; Capo, J.A.; Eyyunni, S.; Mandal, P.K. 2004: Zn2+ and Ca2+ share basolateral ion transporters in lobster hepatopancreatic epithelium. FASEB Journal 18(4-5): Abstract 460
Xu, L.; Pasek, D.A.; Meissner, G. 1999: Zn2+ and Cd2+ inactivate the cardiac and skeletal muscle Ca2+ release channels by interacting with cytosolic channel sites. Biophysical Journal 76(1 Part 2): A303
Lovgren, J.; Lilja, H. 1999: Zn2+ and PCI are important regulators of human glandular kallikrein 2 activity. Journal of Urology 161(4 Suppl): 57
Kown, M.H.; Van Der Steenhoven, T.J.; Blankenberg, F.G.; Hoyt, G.; Strauss, W.; Robbins, R.C. 1999: Zn2+ blocks cardiac allograft apoptosis as measured by Annexin V imaging. Circulation 100(18): 1; 93
Sensi, S.L.; Ton That, D.; Weiss, J.H. 2001: Zn2+ ions, after entry into neurons, are sequestered in mitochondria and rereleased into the cytosol upon subsequent Ca2+ influx. Neurology 56(8 Suppl 3): A367
Sensi, S.L.; Yin, H.Z.; Carriedo, S.G.; Weiss, J.H. 1999: Zn2+ permeation through Ca2+ permeable AMPA/kainate channels triggers prolonged mitochondrial dysfunction. Society for Neuroscience Abstracts 25(1-2): 599
Mokhir, A.; Krämer, R.; Wolf, H. 2004: Zn2+-dependent peptide nucleic acids probes. Journal of the American Chemical Society 126(20): 6208-6209
Schott Ohly, P.; Partke, H.J.; Lgssiar, A.; Friesen, N.T.E.; Buechau, A.S.; Gleichmann, H. 2003: Zn2+-enriched drinking water prevented spontaneous diabetes in NOD mice. Diabetologia 46(Suppl 2): A181
Silva,S.S.; Magalhaes,F.; Sansiviero,M.T.C. 2010: ZnO/TiO2 semiconductor nanocomposites photocatalytic tests. Quimica: 1, 85-89
Yang, G.; Abate, A.; Dennery, P.A. 2003: ZnPP binds to a cellular protein Possible relevance to cell cycle regulation. Pediatric Research 53(4 Part 2): 561A
Santucci, B.; Cristaudo, A.; Mehraban, M.; Valenzano, C.; Camera, E.; Picardo, M. 1999: ZnSO4 treatment of NiSO4-positive patients. Contact Dermatitis 40(5): 281-282
Kuramoto, M.; Yamaguchi, K.; Tsuji, T.; Uemura, D. 2000: Zoanthamines, antiosteoporotic alkaloids. Fusetani, Nobuhiro Author Drugs from the sea 98-106
Ibrahim,M.H.A.; Steinbuchel,A. 2010: Zobellella denitrificans strain MW1, a newly isolated bacterium suitable for poly production from glycerol. Journal of Applied Microbiology 8(1): 214-225
Jonat, W. 2000: ZoladexTM vs CMF as adjuvant therapy in pre-/perimenopausal early breast cancer Preliminary efficacy, QOL and BMD results from the zebra study. Breast Cancer Research and Treatment 64(1): 29
Kaufmann, M. 2001: ZoladexTM vs CMF as adjuvant therapy in pre/perimenopausal, node-positive, early breast cancer Preliminary efficacy results from the ZEBRA Study. Breast 10(Suppl 1): S9-S10
Lipton, A.; Berenson, J.; Porter, L.; Rosen, L.; Levy, E.; Knight, R. 1999: Zoledronate Phase II study in patients with osteolytic bone metastases. Cancer Investigation 17(Suppl 1): 12-13
Sorbera, L.A.; Rabasseda, X.; Castaner, J. 2000: Zoledronate disodium Treatment of tumor-induced hypercalcemia, angiogenesis inhibitor Zoledronic acid disodium salt hydrate , CGP-42446A, ZOL-446, ZometaTM. Drugs of the Future 25(3): 259-268
Jagdev, S.; Croucher, P.; Coleman, R. 2000: Zoledronate induces apoptosis of breast cancer cells in vitro in combination with paclitaxel and tamoxifen Evidence for synergistic effects. British Journal of Cancer 83(Suppl 1): 67
Corso, A.; Ferretti, E.; Lunghi, M.; Maiocchi, M.A.; Zappasodi, P.; Mangiacavalli, S.; Lorenzi, A.; Rusconi, C.; Varettoni, M.; Lazzarino, M. 2003: Zoledronate interferes with the bone marrow stromal cells in multiple myeloma A possible mechanism for its antitumor effect. Blood 102(11): 444a
Chuah, C.; Tipping, A.J.; Goldman, J.M.; Melo, J.V. 2003: Zoledronate is active against imatinib mesylate-resistant chronic myeloid leukemia cell lines and synergistic/additive when combined with imatinib mesylate. Blood 102(11): 19a
Pan, B.; Findlay, D.M.; To, L.B.; Atkins, G.J.; Evdokiou, A.; Labrinidis, A.; Bouralexis, S.; Zannettino, A.C.W. 2002: Zoledronate is anabolic for human osteoblast-like cells. Journal of Bone and Mineral Research 17(Suppl 1): S442
Bonjean, K.; Bellahcene, A.; Locigno, R.; Green, J.; Castronovo, V. 2001: Zoledronate modulates endothelial cell surface receptors involved in angiogenesis. Proceedings of the American Association for Cancer Research 42: 106
Popovic, J.; Jacobson, J.D. 2003: Zoledronate treatment in a patient with severe Osteogenesis Imperfecta. Calcified Tissue International 72(4): 346
Kimura, S.; Kuroda, J.; Ottmann, O.G.; Maekawa, T. 2002: Zoledronate, a Novel Bisphosphonate, Inhibits the Growth of Human Leukemic Cells Both In Vitro and In Vivo. Blood 100(11): Abstract No. 2138
Hupkes, M.; Givant, F. 1999: Zoledronate, a new 3rd generation bisphosphonate Implications for nursing practice. European Journal of Cancer 35(Suppl 4): S44
Guenther, A.; Baum, W.; Burger, R.; Bakker, F.; Faller, G.; Gschaidmeier, H.; Green, J.R.; Gramtzki, M. 2002: Zoledronic Acid Has Direct In Vivo Anti-Myeloma Activity in the INA-6-SCID Model. Blood 100(11): Abstract No. 2365
Baker, J.; Verneris, M.R.; Schimmelpfennig, C.H.; Negrin, R.S. 2002: Zoledronic Acid Is More Effective in Stimulating gammadelta T Cells Than Pamidronate. Blood 100(11): Abstract No. 3699
Myers, B.; Jones, S.G.; Mcmillan, A.K.; Dolan, G. 2002: Zoledronic Acid, Hypocalcaemia and Renal Dysfunction in Thalidomide-Treated Myeloma Patients. Blood 100(11): Abstract No. 792
Walker, K.; Medhurst, S.; Muller, M.; Bowes, M.; Hattenberger, M.; O'reilly, T.; Kidd, B.; Urban, L.; Green, J.R. 2001: Zoledronic acid , a new potent bisphosphonate, reverses mechanical allodynia and limb sparing in a rat model of bone cancer pain. European Journal of Cancer 37(Suppl 6): S64
Perry, C.M.; Figgitt, D.P. 2004: Zoledronic acid: a review of its use in patients with advanced cancer. Drugs 64(11): 1197-1211
Wellington, K.; Goa, K.L. 2003: Zoledronic acid: a review of its use in the management of bone metastases and hypercalcaemia of malignancy. Drugs 63(4): 417-437
Fleisch, H. 2001: Zoledronic acid: an evolving role in the treatment of cancer patients with bone disease. Seminars in Oncology 28(2 Suppl 6: 45-47
Jagdev, S.; Croucher, P.; Rostami, H.A.; Coleman, R. 2001: Zoledronic acid and paclitaxel have synergistic effects on breast cancer cell apoptosis in vitro evidence from isobolgram and grafit software analysis. British Journal of Cancer 85(Suppl 1): 47
Little, D.G.; Williams, P.R.; Smith, N.C.; Smith, E.J.; Briody, J.; Cowell, C.T.; Bilston, L.E. 2001: Zoledronic acid enhances bone formation and mineralization in distraction osteogenesis in immature rabbits. Journal of Bone and Mineral Research 16(Suppl 1): S239
Coleman, R.; Gralow, J.; Bell, R.; Lipton, A. 2004: Zoledronic acid for the prevention of bone metastases in patients with breast cancer. EJC Suppls 2(3): 74-75
Lacerna, L.; Hohneker, J. 2003: Zoledronic acid for the treatment of bone metastases in patients with breast cancer and other solid tumors. Seminars in Oncology 30(5 Suppl 16: 150-160
Coleman, R.; Rosen, L.; Zheng, M. 2004: Zoledronic acid has long-term efficacy in reducing skeletal complications in patients with bone metastases from breast cancer. EJC Suppls 2(3): 127-128
Peat, R.A.; Mcevoy, A.; Williams, P.R.; Baldock, P.A.; Smith, E.J.; Little, D.G. 2002: Zoledronic acid improves short-term outcome in traumatic osteonecrosis in young wistar rats. Journal of Bone and Mineral Research 17(Suppl 1): S213
Berenson, J.R. 2001: Zoledronic acid in cancer patients with bone metastases: results of Phase i and Ii trials. Seminars in Oncology 28(2 Suppl 6: 25-34
Melisi, D.; Caputo, R.; Caputo, R.; Bianco, R.; Bianco, A.R.; Ciardiello, F.; Tortora, G. 2003: Zoledronic acid in combination with a COX-2 inhibitor and gefitinib cooperatively inhibits growth and angiogenenic factor expression and secretion in breast and prostate carcinoma cells. Proceedings of the American Association for Cancer Research 44: 1347-1348
Major, P.P.; Coleman, R.E. 2001: Zoledronic acid in the treatment of hypercalcemia of malignancy: results of the international clinical development program. Seminars in Oncology 28(2 Suppl. 6): 17-24
Coxon, J.P.; Pickering, L.M.; Colston, K.W. 2003: Zoledronic acid induces apoptosis and inhibits adhesion of breast and prostate cancer cells via inhibition of protein prenylation. British Journal of Cancer 88(Suppl 1): S25
Montague, R.J.; Hart, C.; Brown, M.; Ramani, V.A.; George, N.; Clarke, N.W. 2003: Zoledronic acid inhibits invasion and proliferation of prostate epithelia in human bone marrow. Journal of Urology 169(4 Suppl): 220-221
Kim, S.J.; Uehara, H.; Karashima, T.; Shepherd, D.L.; Van Arsdall, M.R.; Fan, D.; Killion, J.J.; Fidler, I.J. 2002: Zoledronic acid inhibits the growth of human prostate cancer cells implanted into the tibia of nude mice and preserves bone structure by inhibition of osteoclast function. Proceedings of the American Association for Cancer Research 43: 91
Rosen, L.; Coleman, R.; Gordon, D.; Major, P.; Kaminski, M.; Apffelstaedt, J.; Howell, A.; Chen, B.L.; Seaman, J. 2003: Zoledronic acid is superior to pamidronate in patients with breast cancer and bone metastases. Breast 12(Suppl 1): S42-S43
Saad, F.; Gleason, D.; Murray, R.; Venner, P.; Tchekmedyian, S.; Lacombe, L.; Chin, J.; Vinholes, J.; Goas, J.A.; Chen, B.L.; Seaman, J. 2003: Zoledronic acid is well tolerated for up to 24 months and significantly reduces skeletal complications in patients with advanced prostate cancer metastatic to bone. Journal of Urology 169(4 Suppl): 394
Smith, E.J.; Peat, R.A.; Mcevoy, A.; Briody, J.N.; Baldock, P.A.; Eisman, J.A.; Little, D.G.; Gardiner, E.M. 2002: Zoledronic acid modulates bone repair through transiently delayed remodelling. Journal of Bone and Mineral Research 17(Suppl 1): S199
Crawford, B.A.L.; Kam, C.; Pavlovic, J.; Donaghy, A.J.; Angus, P.; Mccaughan, G. 2003: Zoledronic acid prevents bone loss at 3 months in liver transplant patients An interim analysis. Hepatology 38(4 Suppl 1): 257A
Hausmaninger, H. 2003: Zoledronic acid prevents bone mineral density loss in premenopausal women receiving adjuvant treatment for hormone receptor-positive breast cancer Preliminary results of a randomized, multicenter trial of zoledronic acid in patients receiving anastrozole or tamoxifen in combination with goserelin. Breast 12(Suppl 1): S43
Berenson, J.; Rosen, L.; Howell, A.; Porter, L.; Coleman, R.; Morley, W.; Dreicer, R.; Kuross, S.; Lipton, A.; Seaman, J. 2000: Zoledronic acid reduces skeletal related events in patients with osteolytic metastases A double-blind, randomized dose response study. Breast Cancer Research and Treatment 64(1): 32
Fred, S.; Gleason, D.; Murray, R.; Venner, P.; Tchekmediyian, S.; Chin, J.; Goas, A.; Reitsma, D.; Seaman, J. 2002: Zoledronic acid significantly reduces fractures in patients with hormone-refractory prostate cancer metastatic to bone. Journal of Urology 167(4 Suppl): 175
Coleman, R.E.; Rosen, L.S.; Gordon, D.; Major, P.; Kaminski, M.; Apffelstaedt, J.; Howell, A.; Chen, B.L.; Seaman, J.J. 2002: Zoledronic acid significantly reduces the relative risk of developing a skeletal-related event compared with pamidronate in patients with breast cancer and bone metastasis. Breast Cancer Research and Treatment 76(Suppl 1): S95
Brown, J.P.; Burckhardt, P.; Reid, I.R.; Horowitz, Z.D.; Richardson, P.C.; Trechsel, U. 2001: Zoledronic acid, at a total annual dose of 4 mg, increases bone density at all sites and stably reduces bone turnover for one year when administered as a single or a 3-monthly intravenous injection in postmenopausal osteoporosis. Journal of Bone and Mineral Research 16(Suppl 1): S218
Satoskar, A.A.; Ellison, E.C.; Vlasoff, D.; Frankel, W.L. 2002: Zollinger-Ellison syndrome Correlation between histopathologic findings and survival. Laboratory Investigation 82(1): 119A-120A
Metz, D.C.; Forsmark, C.E.; Soffer, E.; Bochenek, W.; Beg, M.; Pisegna, J.R. 1999: Zollinger-Ellison syndrome patients can replace oral proton pump inhibitors with intravenous pantoprazole without losing control of acid output. Gastroenterology 116(4 Part 2): A252
Loder, E.; Abu Shakra, S.; Ward, T.; Rapoport, A. 2003: Zolmitriptan 25 mg orally disintegrating tablet achieves high pain-free rates in the acute treatment of migraine Results of a randomized, double-blind, placebo-controlled Study. Neurology 60(5 Suppl 1): A236
Dowson, A.J.; Purdy, A.; Macgregor, E.A. 2001: Zolmitriptan 25 mg orally disintegrating tablet for acute treatment of migraine Part I, efficacy and tolerability. Neurology 56(8 Suppl 3): A219
Purdy, A.; Macgregor, E.A.; Dowson, A.J. 2001: Zolmitriptan 25 mg orally disintegrating tablet for acute treatment of migraine Part II-patient preference for a new formulation. Neurology 56(8 Suppl 3): A357-A358
Spierings, E.L.H.; Abu Shakra, S.; Dodick, D.; Johnson, C. 2003: Zolmitriptan 5 mg orally disintegrating tablets delivers a 30-minute onset of action and high sustained headache response in a placebo-controlled Trial. Neurology 60(5 Suppl 1): A253
Spencer, C.M.; Gunasekara, N.S.; Hills, C. 1999: Zolmitriptan: a review of its use in migraine. Drugs 58(2): 347-374
Linder, S.L.; Dowson, A. 1999: Zolmitriptan An effective treatment for adolescent migraine. Neurology 52(6 Suppl 2): A205
Rapoport, A.; Dowson, A.; Charlesworth, B.; Hughes, J.; Syrett, N. 2003: Zolmitriptan conventional and orally disintegrating tablets achieve headache response as early as 30 min post-treatment Results of a pooled data analysis. Cephalalgia 23(7): 718
Silberstein, S.D.; Loder, E.; Elkind, A.; Abu Shakra, S. 2002: Zolmitriptan in the treatment of migraine associated with menses The influence of age on efficacy and tolerability. Neurology 58(7 Suppl 3): A290-A291